,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line,Confirmatory,,
1,3,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line,Confirmatory,,
2,5,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Confirmatory,,
3,7,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Confirmatory,,
4,9,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Confirmatory,,
5,11,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line,Confirmatory,,
6,13,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line,Confirmatory,,
7,15,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Confirmatory,,
8,17,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line,Confirmatory,,
9,19,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Confirmatory,,
10,21,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line,Confirmatory,,
11,23,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Confirmatory,,
12,25,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line,Confirmatory,,
13,27,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line,Confirmatory,,
14,29,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line,Confirmatory,,
15,31,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line,Confirmatory,,
16,33,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Confirmatory,,
17,35,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line,Confirmatory,,
18,37,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Confirmatory,,
19,39,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Confirmatory,,
20,45,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Confirmatory,,
21,47,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Confirmatory,,
22,49,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line,Confirmatory,,
23,51,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line,Confirmatory,,
24,53,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Confirmatory,,
25,55,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line,Confirmatory,,
26,57,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line,Confirmatory,,
27,59,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Confirmatory,,
28,61,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line,Confirmatory,,
29,63,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line,Confirmatory,,
30,65,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line,Confirmatory,,
31,67,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Confirmatory,,
32,69,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line,Confirmatory,,
33,71,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Confirmatory,,
34,73,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line,Confirmatory,,
35,75,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line,Confirmatory,,
36,77,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Confirmatory,,
37,79,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Confirmatory,,
38,81,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line,Confirmatory,,
39,99,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line,Confirmatory,,
40,101,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line,Confirmatory,,
41,103,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line,Confirmatory,,
42,105,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Confirmatory,,
43,107,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Confirmatory,,
44,109,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line,Confirmatory,,
45,113,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line,Confirmatory,,
46,115,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line,Confirmatory,,
47,119,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Confirmatory,,
48,121,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line,Confirmatory,,
49,123,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Confirmatory,,
50,125,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Confirmatory,,
51,129,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line,Confirmatory,,
52,131,1,1,,477072,5281855,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Confirmatory,,
53,133,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line,Confirmatory,,
54,135,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF-631 Renal cell line,Confirmatory,,
55,137,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line,Confirmatory,,
56,139,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line,Confirmatory,,
57,141,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line,Confirmatory,,
58,143,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line,Confirmatory,,
59,145,1,1,,477072,5281855,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line,Confirmatory,,
60,155,1,1,,477072,5281855,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
61,155,1,1,,507093,5281855,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
62,157,1,1,,477072,5281855,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
63,157,1,1,,507093,5281855,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
64,161,1,1,,477072,5281855,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
65,161,1,1,,507093,5281855,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
66,165,1,1,,477072,5281855,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
67,165,1,1,,507093,5281855,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
68,167,1,1,,477072,5281855,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
69,167,1,1,,507093,5281855,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
70,175,1,1,,477072,5281855,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
71,175,1,1,,507093,5281855,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
72,179,1,1,,507093,5281855,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
73,200,1,1,,477072,5281855,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6C3F1 mice,Other,,
74,206,1,1,,477072,5281855,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
75,212,1,1,,477072,5281855,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Colon Carcinoma 38 (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
76,256,1,1,,477072,5281855,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
77,264,1,1,,477072,5281855,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
78,274,1,1,,477072,5281855,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (intravenous) in B6D2F1 (BDF1) mice,Other,,
79,276,1,1,,477072,5281855,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (intravenous) in B6C3F1 mice,Other,,
80,292,1,1,,477072,5281855,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Sarcoma M5076 (intraperitoneal) in B6C3F1 mice,Other,,
81,296,1,1,,477072,5281855,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
82,330,1,1,,477072,5281855,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
83,363,3,2,,8033769,5281855,Active,125711.0,6714.0,,,Literature data for small-molecule inhibitors of Human Src.,Other,7518523.0,
84,410,1,5,,11113162,5281855,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
85,411,2,1,,11113162,5281855,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
86,425,3,2,,8139882,5281855,Active,16758752.0,116663.0,39.5,IC50,MKP-3 in vitro HTS assay,Confirmatory,,
87,445,3,1,,11113162,5281855,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
88,447,1,1,,11113162,5281855,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
89,448,1,2,,11113162,5281855,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
90,450,1,2,,11113162,5281855,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
91,451,1,2,,11113162,5281855,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
92,485,1,8,,8139882,5281855,Inactive,38788193.0,1903.0,,,Primary HTS Assay for S1P3 Antagonists,Screening,,
93,526,1,1,,11113162,5281855,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
94,530,1,1,,11113162,5281855,Active,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
95,568,1,7,,8139882,5281855,Active,5729877.0,3312.0,99.2,IC50,High Throughput Screening Assay for Hsc70 Inhibitors,Confirmatory,,
96,568,1,7,,8139882,5281855,Active,24234686.0,3312.0,99.2,IC50,High Throughput Screening Assay for Hsc70 Inhibitors,Confirmatory,,
97,583,2,6,,8139882,5281855,Active,123271505.0,,0.76,IC50,High Throughput Screening Assay for Hsp70 Inhibitors,Confirmatory,,
98,584,1,3,,11113162,5281855,Inconclusive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
99,585,1,4,,11113162,5281855,Active,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
100,587,1,5,,11113162,5281855,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
101,588,1,4,,11113162,5281855,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
102,589,1,3,,11113162,5281855,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
103,590,1,3,,11113162,5281855,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
104,591,1,4,,11113162,5281855,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
105,592,1,6,,11113162,5281855,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
106,593,1,4,,11113162,5281855,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
107,594,1,4,,11113162,5281855,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
108,595,1,3,,11113162,5281855,Active,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
109,596,1,2,,11113162,5281855,Inconclusive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
110,597,1,3,,11113162,5281855,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
111,598,1,4,,8139882,5281855,Active,,,,,Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen,Screening,,
112,602,1,4,,8139882,5281855,Inactive,,,,,Identification of Molecular Probes that Reverse MRP-Mediated Drug Resistance,Screening,,
113,603,1,2,,11113162,5281855,Active,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
114,605,1,2,,11113162,5281855,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
115,606,1,3,,8139882,5281855,Inactive,224586929.0,26191.0,,,HTS for LYP Inhibitors-an Autoimmunity Target - Primary screen,Confirmatory,,
116,606,1,3,,8139882,5281855,Inactive,301171662.0,26191.0,,,HTS for LYP Inhibitors-an Autoimmunity Target - Primary screen,Confirmatory,,
117,607,1,3,,11113162,5281855,Inconclusive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
118,608,1,6,,11537684,5281855,Inactive,17149836.0,2280.0,,,NMR Based Screening Assay for FKBP12,Other,,
119,618,2,6,,8139882,5281855,Inactive,6690534.0,4323.0,,EC50,Luminescent HTS for small molecule inhibitors of MT1-MMP transcription,Confirmatory,,
120,620,2,5,,8139882,5281855,Inactive,,,,EC50,Fluorescent HTS Cytotoxicity/Cell viability assay (HT1080 cells),Confirmatory,,
121,629,1,3,,8139882,5281855,Active,118764400.0,2099.0,,,HTS of Estrogen Receptor- alpha Coactivator Binding inhibitors,Screening,,
122,630,1,1,,8139882,5281855,Active,5174513.0,4088.0,,,HTS of Smad transcription factor inhibitors,Screening,,
123,631,1,4,,8139882,5281855,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
124,631,1,4,,8139882,5281855,Inactive,22538455.0,8648.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
125,633,1,3,,8139882,5281855,Active,10835013.0,2100.0,,,HTS for Estrogen Receptor-beta Coactivator Binding inhibitors,Screening,,
126,639,1,2,,8139882,5281855,Inactive,118764400.0,2099.0,,,HTS of Estrogen Receptor- alpha Coactivator Binding Potentiators,Screening,,
127,648,1,3,,8139882,5281855,Inactive,,,,,Human Endothelial Cell Proliferation Assay in 384-well format,Screening,,
128,662,1,1,,11113162,5281855,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
129,687,1,17,,8139882,5281855,Inactive,180352.0,,,,Factor XIa Single Well HTS,Screening,,
130,701,1,17,,8139882,5281855,Inactive,317373446.0,2161.0,,,Factor XIIa Single Well HTS,Screening,,
131,715,1,2,,8139882,5281855,Active,5174513.0,4088.0,0.142,IC50,SMAD Transcription Factor Inhibitors Dose Response Confirmation,Confirmatory,,
132,719,1,3,,8139882,5281855,Inactive,,,,,Human Lung Fibroblast Proliferation Assay,Screening,,
133,731,1,5,,8139882,5281855,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
134,731,1,5,,8139882,5281855,Inactive,32307126.0,8202.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
135,750,1,3,,8139882,5281855,Inactive,,,,,Luminescent HTS for small molecule activators of MT1-MMP transcription,Screening,,
136,757,1,4,,8139882,5281855,Inconclusive,8574038.0,5879.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac wildtype,Screening,,
137,758,1,4,,8139882,5281855,Inconclusive,164058.0,404007.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab7 wildtype,Screening,,
138,759,1,4,,8139882,5281855,Inconclusive,190938.0,3265.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype,Screening,,
139,760,1,4,,8139882,5281855,Inconclusive,46577642.0,404009.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype,Screening,,
140,761,1,4,,8139882,5281855,Inconclusive,56202836.0,,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype,Screening,,
141,764,1,4,,8139882,5281855,Inconclusive,8574038.0,5879.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac activated mutant,Screening,,
142,775,1,3,,8139882,5281855,Inactive,,,,,Screen for Chemicals that Extend Yeast Lifespan,Screening,,
143,781,1,1,,8139882,5281855,Active,27807367.0,287022.0,,,uHTS for 14-3-3/Bad interaction inhibitors,Screening,,
144,782,1,2,,8139882,5281855,Active,83627717.0,13684.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
145,782,1,2,,8139882,5281855,Active,302699239.0,1981.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
146,786,2,3,,8139882,5281855,Inactive,123271505.0,,100.0,IC50,TR-FRET secondary assay for HTS discovery of chemical inhibitors of Hsp70,Confirmatory,,
147,793,1,2,,8139882,5281855,Inactive,4505447.0,4887.0,,,Primary cell based high-throughput screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2),Screening,,
148,797,1,1,,8139882,5281855,Inactive,115529463.0,5587.0,,,Fluorescence polarization assay for PKD inhibitors,Screening,,
149,798,2,12,,8139882,5281855,Inactive,180352.0,,,,Factor XIa 1536 HTS,Screening,,
150,799,1,5,,8139882,5281855,Inactive,134142337.0,4363.0,,,Identification of Molecular Probes that Activate MRP-1,Screening,,
151,800,2,11,,8139882,5281855,Inactive,317373446.0,2161.0,,,Factor XIIa 1536 HTS,Screening,,
152,803,1,4,,8139882,5281855,Inactive,6016094.0,8811.0,,,Primary cell-based high-throughput screening assay to identify agonists of Galanin Receptor 2 (GALR2),Screening,,
153,804,1,3,,8139882,5281855,Inactive,,,,,Screen for Chemicals that Shorten Yeast Lifespan,Screening,,
154,817,1,1,,8139882,5281855,Inactive,1360328.0,,,,Identification and characterization of compounds for addressing human bone marrow failure,Other,,
155,818,1,2,,8139882,5281855,Inactive,,,,,High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression,Screening,,
156,827,1,2,,8139882,5281855,Inactive,,,,,High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor,Screening,,
157,828,1,5,,8139882,5281855,Inactive,6016094.0,8811.0,,,Primary cell-based high-throughput screening assay to identify antagonists of Galanin Receptor 2 (GALR2),Screening,,
158,834,1,3,,8139882,5281855,Inactive,,,,,C. albicans biofilm killing,Screening,,
159,841,1,1,,8139882,5281855,Inactive,,,,,Non-Nucleoside Inhibitor of Measles Virus RNA-Dependent RNA Polymerase Complex Activity HTS Single Point (MLSMR Library),Screening,,
160,855,1,3,,8139882,5281855,Inactive,83627717.0,13684.0,47.6714,Absolute IC50,Dose Response Confirmation for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Confirmatory,,
161,855,1,3,,8139882,5281855,Inactive,302699239.0,1981.0,47.6714,Absolute IC50,Dose Response Confirmation for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Confirmatory,,
162,861,1,1,,8139882,5281855,Inactive,55662034.0,,,,Primary cell-based high-throughput screening assay for inhibitors of TLR4-MyD88 binding,Screening,,
163,862,1,2,,8139882,5281855,Inactive,13272532.0,6774.0,,,Primary cell-based high throughput screening assay to measure STAT3 inhibition,Screening,,
164,868,1,3,,8139882,5281855,Inactive,,,,,Screen for Chemicals that Inhibit the RAM Network,Screening,,
165,871,1,2,,8139882,5281855,Inactive,13272532.0,6774.0,,,Primary cell-based high throughput screening assay to measure STAT3 activation,Screening,,
166,873,1,13,,8139882,5281855,Inactive,6912644.0,25818.0,,,Kallikrein 5 1536 HTS,Screening,,
167,875,1,2,,26748644,5281855,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
168,875,1,2,,26753737,5281855,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
169,878,1,2,,8139882,5281855,Inactive,,,,,NIH Compound Library Profiling: Compound and DTT Dependent Redox Cycling H2O2 Generation.,Screening,,
170,880,2,1,,8139882,5281855,Active,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
171,880,2,1,,8139882,5281855,Active,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
172,880,2,1,,26748644,5281855,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
173,880,2,1,,26748644,5281855,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
174,880,2,1,,26753737,5281855,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
175,880,2,1,,26753737,5281855,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
176,881,2,2,,26748644,5281855,Inactive,317373425.0,247.0,1.2589,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
177,881,2,2,,26753737,5281855,Inactive,317373425.0,247.0,6.3096,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
178,883,1,3,,11113162,5281855,Inconclusive,13699818.0,1559.0,39.8107,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
179,884,1,2,,26748644,5281855,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
180,884,1,2,,26753737,5281855,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
181,885,1,2,,26748644,5281855,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
182,885,1,2,,26753737,5281855,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
183,886,1,2,,11113162,5281855,Active,122921310.0,,0.2512,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
184,886,1,2,,11113162,5281855,Active,122921311.0,,0.2512,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
185,887,1,2,,26748644,5281855,Inconclusive,1832253.0,246.0,5.0119,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
186,887,1,2,,26753737,5281855,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
187,889,1,3,,26748644,5281855,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
188,889,1,3,,26753737,5281855,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
189,891,1,2,,11113162,5281855,Inactive,40805836.0,1565.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
190,892,1,2,,26748644,5281855,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
191,892,1,2,,26753737,5281855,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
192,893,1,2,,26748644,5281855,Inconclusive,122921310.0,,1.5849,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
193,893,1,2,,26748644,5281855,Inconclusive,122921311.0,,1.5849,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
194,893,1,2,,26753737,5281855,Inconclusive,122921310.0,,3.1623,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
195,893,1,2,,26753737,5281855,Inconclusive,122921311.0,,3.1623,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
196,894,2,1,,8139882,5281855,Active,31542939.0,3248.0,0.8913,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
197,894,2,1,,26748644,5281855,Active,31542939.0,3248.0,0.1259,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
198,894,2,1,,26753737,5281855,Active,31542939.0,3248.0,0.8913,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
199,898,1,1,,8139882,5281855,Inactive,28373018.0,1239205.0,,,YopH  HTS,Screening,,
200,899,1,2,,11113162,5281855,Active,4503219.0,1557.0,31.6228,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
201,900,1,3,,26748644,5281855,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
202,900,1,3,,26753737,5281855,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
203,901,1,2,,26753737,5281855,Inconclusive,44888968.0,83523.0,15.8489,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
204,902,1,2,,26748644,5281855,Inconclusive,120407068.0,7157.0,12.5893,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
205,902,1,2,,26753737,5281855,Inconclusive,120407068.0,7157.0,31.6228,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
206,910,1,2,,26748644,5281855,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus,Confirmatory,,
207,912,1,2,,11113162,5281855,Inconclusive,21392848.0,,1.0,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
208,920,1,2,,8139882,5281855,Inactive,6274552.0,6772.0,,,Primary cell-based high throughput screening assay to measure STAT1 inhibition,Screening,,
209,923,1,2,,26748644,5281855,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
210,923,1,2,,26753737,5281855,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
211,924,1,2,,26748644,5281855,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
212,924,1,2,,26753737,5281855,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
213,926,1,2,,11113162,5281855,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
214,927,1,3,,26748644,5281855,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
215,930,1,2,,26748644,5281855,Active,4504349.0,3043.0,10.0,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus,Confirmatory,,
216,932,1,4,,8139882,5281855,Inactive,6274552.0,6772.0,,,Primary cell-based high throughput screening assay to measure STAT1 activation,Screening,,
217,938,1,2,,11113162,5281855,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
218,940,1,2,,8139882,5281855,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
219,940,1,2,,26612352,5281855,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
220,950,1,1,,8139882,5281855,Inactive,231632.0,596.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-2.",Screening,,
221,951,1,1,,8139882,5281855,Inactive,23396469.0,10017.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-B.",Screening,,
222,952,1,1,,8139882,5281855,Inactive,1572493.0,599.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-W.",Screening,,
223,995,1,2,,26748644,5281855,Active,66932916.0,5594.0,19.9526,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
224,995,1,2,,26753737,5281855,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
225,1001,2,2,,8139882,5281855,Inactive,116734717.0,249.0,,EC50,uHTS identification of compounds activating TNAP in the absence of phosphate acceptor performed in luminescent assay,Confirmatory,,
226,1006,1,6,,8139882,5281855,Inactive,,,,,Counter Screen for Luciferase-based Primary Inhibition Assays,Screening,,
227,1007,1,1,,8139882,5281855,Inactive,510901.0,598.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL.",Screening,,
228,1008,1,2,,8139882,5281855,Inactive,4757840.0,597.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bfl-1",Screening,,
229,1009,1,2,,8139882,5281855,Inactive,7582271.0,4170.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1",Screening,,
230,1012,1,4,,8139882,5281855,Inactive,116734717.0,249.0,,,uHTS identification of TNAP inhibitors in the absence of phosphate acceptor performed in luminescent assay,Screening,,
231,1016,1,4,,8139882,5281855,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of activators of bovine intestinal alkaline phosphatase,Screening,,
232,1018,2,5,,8139882,5281855,Inactive,8744934.0,,,IC50,Chemical Antagonists IAP-family anti-apoptotic proteins,Confirmatory,,
233,1019,1,4,,8139882,5281855,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of inhibitors of bovine intestinal alkaline phosphatase,Screening,,
234,1020,1,5,,8139882,5281855,Inactive,149631.0,,,,Counter Screen for Glucose-6-Phosphate Dehydrogenase-based Primary Assay,Screening,,
235,1021,1,1,,8139882,5281855,Active,7582271.0,4170.0,,,uHTS of Mcl-1/Bid interaction inhibitors,Screening,,
236,1022,1,1,,8139882,5281855,Active,7582271.0,4170.0,,,uHTS of Mcl-1/Noxa interaction inhibitors,Screening,,
237,1027,1,3,,8139882,5281855,Inactive,,,,,Counter Screen for Luciferase-based Primary Stimulation Assays,Screening,,
238,1030,2,1,,8139882,5281855,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
239,1030,2,1,,26748644,5281855,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
240,1030,2,1,,26753737,5281855,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
241,1032,1,2,,8139882,5281855,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
242,1032,1,2,,8139882,5281855,Inactive,62201602.0,,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
243,1033,2,2,,11537684,5281855,Inactive,216546.0,,,,NMR Based Screening Assay for the substrate binding domain of the chaperone DnaK,Screening,,
244,1040,1,2,,8139882,5281855,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for antagonists of NPY-Y1,Screening,,
245,1046,1,6,,8139882,5281855,Inactive,339641.0,2147.0,,,Thrombin 1536 HTS,Screening,,
246,1048,1,1,,8139882,5281855,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
247,1048,1,1,,8139882,5281855,Inactive,32307126.0,8202.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
248,1049,1,1,,8139882,5281855,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
249,1049,1,1,,8139882,5281855,Inactive,62201602.0,,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
250,1051,1,1,,8139882,5281855,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
251,1051,1,1,,8139882,5281855,Inactive,22538455.0,8648.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
252,1063,1,1,,8139882,5281855,Inactive,,,,,Leishmania major promastigote HTS,Screening,,
253,1066,1,2,,8139882,5281855,Active,9937384.0,,,,High Throughput Screen to Identify Compounds that Inhibit Class II HMG-CoA Reductases  - Primary Screen,Screening,,
254,1072,1,3,,26514067,5281855,Inactive,123271505.0,,100.0,IC50,In Vitro Hsp70 Dose Response Fluorescence Polarization Assay for SAR Study,Confirmatory,,
255,1085,1,1,,8139882,5281855,Active,139424501.0,5176170.0,,,uHTS for Small Molecule Inhibitiors of Epstein-Barr Virus Inhibitors,Screening,,
256,1135,1,3,,8139882,5281855,Inactive,116734717.0,249.0,,,uHTS identification of compounds inhibiting TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
257,1136,1,3,,8139882,5281855,Inactive,116734717.0,249.0,,,uHTS identification of compounds activating TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
258,1189,1,5,,48413710,5281855,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
259,1193,1,3,,26514067,5281855,Inactive,5729877.0,3312.0,100.0,IC50,In Vitro Hsc70 Dose Response Fluorescence Polarization Assay,Confirmatory,,
260,1193,1,3,,26514067,5281855,Inactive,24234686.0,3312.0,100.0,IC50,In Vitro Hsc70 Dose Response Fluorescence Polarization Assay,Confirmatory,,
261,1194,1,3,,48413710,5281855,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity,Other,,
262,1203,1,3,,8139882,5281855,Inactive,12803275.0,3303.0,,,Primary cell-based high-throughput screening assay to identify transcriptional activators of heat shock protein 70 (Hsp70),Screening,,
263,1208,1,3,,48413710,5281855,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results,Other,,
264,1209,2,2,,8139882,5281855,Active,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Confirmatory,,
265,1210,1,1,,8139882,5281855,Inactive,6166154.0,2100.0,,,Estrogen Receptor (beta) binding:  Primary Screen,Screening,,
266,1211,1,1,,8139882,5281855,Inactive,5821726.0,2099.0,,,Estrogen Receptor (alpha) binding: Primary Screen,Screening,,
267,1214,1,4,,8139882,5281855,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Screening,,
268,1216,1,5,,8139882,5281855,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay using a near- saturating concentration of mannose 6-phosphat,Screening,,
269,1217,1,4,,8139882,5281855,Active,17391426.0,1738.0,,,uHTS Identification of Diaphorase Inhibitors and Chemcical Oxidizers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
270,1220,2,2,,8139882,5281855,Active,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay using a high concentration of mannose 6-phosphate,Confirmatory,,
271,1222,1,6,,8139882,5281855,Inactive,,,,EC50,High Throughput Screen for Inhibitors of ER Stress-induced Cell Death in a 384 well format.,Confirmatory,,
272,1229,1,3,,8139882,5281855,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Activators and Chemical Reducers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
273,1233,1,1,,8139882,5281855,Active,9937384.0,,1265.39,IC50,High Throughput Screen to Identify Compounds that Inhibit Class II HMG-CoA Reductases  - Confirmatory Screen,Confirmatory,,
274,1236,1,1,,8139882,5281855,Inactive,1628587.0,397393.0,,,uHTS for Calpain Inhibitors,Screening,,
275,1239,1,3,,8139882,5281855,Inactive,34577122.0,4790.0,,,High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen,Screening,,
276,1239,1,3,,8139882,5281855,Inactive,223468676.0,5970.0,,,High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen,Screening,,
277,1242,1,1,,8139882,5281855,Inactive,11094021.0,,,,C. albicans biofilm killing---Mixture HTS,Screening,,
278,1251,1,1,,8139882,5281855,Inactive,,,,,"Anti-Viral Drugs Against Arbovirus Infections, a Primary Screen",Screening,,
279,1273,1,1,,8139882,5281855,Inactive,59036749.0,3630.0,,,Primary screen for compounds that inhibit Insulin promoter activity in TRM-6 cells,Screening,,
280,1274,1,2,,8139882,5281855,Inactive,115298672.0,653361.0,,,"uHTS of small molecular inhibitors for p47phox, a regulatory protein of NADPH oxidases (Noxs)",Screening,,
281,1276,1,1,,8139882,5281855,Inactive,257380.0,351.0,,,Primary screen for compounds that activate Alzheimer's amyloid precursor,Screening,,
282,1285,1,1,,8139882,5281855,Inactive,257380.0,351.0,,,Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation,Screening,,
283,1296,1,1,,8139882,5281855,Inactive,59036749.0,3630.0,,,Primary screen for compounds that activate Insulin promoter activity in TRM-6 cells,Screening,,
284,1304,1,2,,8139882,5281855,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y1,Screening,,
285,1321,1,2,,8139882,5281855,Inactive,47123300.0,7465.0,,,Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation,Screening,,
286,1325,1,2,,8139882,5281855,Inactive,62526033.0,9429.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCG2 screen, ABCB1 counter-screen",Screening,,
287,1326,1,4,,8139882,5281855,Inactive,42741659.0,5243.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCB1 screen, ABCG2 counter-screen",Screening,,
288,1359,1,4,,8139882,5281855,Inactive,4505447.0,4887.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y2,Screening,,
289,1362,1,2,,8139882,5281855,Inactive,,,,,Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Primary Screen,Screening,,
290,1377,1,1,,8139882,5281855,Inactive,,,,,HTS to identify inhibitors of zVAD Induced Cell Death in L929 Cells.,Screening,,
291,1379,1,2,,8139882,5281855,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
292,1379,1,2,,26748644,5281855,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
293,1379,1,2,,26753737,5281855,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
294,1381,1,1,,8139882,5281855,Inactive,,,,,HCS to Identify Inhibitors of Dynein Mediated Cargo Transport on Microtubules.,Screening,,
295,1415,1,2,,8139882,5281855,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
296,1415,1,2,,8139882,5281855,Inactive,86301151.0,5999.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
297,1416,1,2,,8139882,5281855,Inactive,134304838.0,9451.0,,,Primary cell-based high-throughput screening assay to measure PERK inhibition,Screening,,
298,1417,1,1,,8139882,5281855,Active,7582271.0,4170.0,54.0,IC50,Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors,Confirmatory,,
299,1418,1,1,,8139882,5281855,Active,7582271.0,4170.0,0.57,Absolute IC50,Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors,Confirmatory,,
300,1422,1,1,,26612352,5281855,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
301,1423,1,2,,8139882,5281855,Active,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
302,1423,1,2,,8139882,5281855,Active,74355113.0,85397.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
303,1424,1,1,,8139882,5281855,Inactive,34330186.0,368273.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel N1 (TRPN1),Screening,,
304,1430,1,1,,8139882,5281855,Active,70832125.0,3663016.0,,,HTS assay for inhibitors of Trypanosoma brucei hexokinase 1,Screening,,
305,1434,2,3,,8139882,5281855,Inactive,13124881.0,865.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
306,1434,2,3,,8139882,5281855,Inactive,19923198.0,861.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
307,1439,1,1,,8139882,5281855,Active,1166512.0,6000.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
308,1439,1,1,,8139882,5281855,Active,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
309,1440,1,1,,8139882,5281855,Inconclusive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
310,1440,1,1,,8139882,5281855,Inconclusive,86990435.0,10287.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
311,1441,1,1,,8139882,5281855,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
312,1441,1,1,,8139882,5281855,Inactive,156416009.0,6004.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
313,1443,1,3,,8139882,5281855,Inactive,4507593.0,8743.0,,,uHTS for the identification of compounds that potentiate TRAIL-induced apoptosis of cancer cells,Screening,,
314,1445,1,1,,8139882,5281855,Inconclusive,124512980.0,813945.0,,IC50,Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP),Confirmatory,,
315,1446,1,3,,8139882,5281855,Inactive,119579178.0,3717.0,,,Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F,Screening,,
316,1448,1,3,,8139882,5281855,Inactive,38174238.0,55283.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel ML3 (TRPML3),Screening,,
317,1452,1,1,,8139882,5281855,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
318,1452,1,1,,26748644,5281855,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
319,1452,1,1,,26753737,5281855,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
320,1454,1,1,,8139882,5281855,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
321,1454,1,1,,26748644,5281855,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
322,1454,1,1,,26753737,5281855,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
323,1456,1,1,,8139882,5281855,Inactive,12003227.0,57468.0,,,Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Primary Screen,Other,,
324,1457,1,1,,8139882,5281855,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
325,1457,1,1,,26748644,5281855,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
326,1457,1,1,,26753737,5281855,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
327,1458,1,1,,8139882,5281855,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
328,1458,1,1,,26748644,5281855,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
329,1460,1,3,,8139882,5281855,Active,92096784.0,4137.0,14.1254,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
330,1460,1,3,,26748644,5281855,Active,92096784.0,4137.0,12.5893,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
331,1460,1,3,,26753737,5281855,Active,92096784.0,4137.0,31.6228,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
332,1461,1,2,,8139882,5281855,Inactive,46395496.0,387129.0,,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
333,1463,1,1,,8139882,5281855,Inconclusive,,,19.9526,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
334,1463,1,1,,26748644,5281855,Inconclusive,,,15.8489,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
335,1463,1,1,,26753737,5281855,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
336,1466,1,2,,8139882,5281855,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
337,1467,1,3,,8139882,5281855,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
338,1467,1,3,,26748644,5281855,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
339,1467,1,3,,26753737,5281855,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
340,1468,1,1,,8139882,5281855,Inconclusive,92096784.0,4137.0,35.4813,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
341,1468,1,1,,26748644,5281855,Inconclusive,92096784.0,4137.0,22.3872,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
342,1468,1,1,,26753737,5281855,Inconclusive,92096784.0,4137.0,39.8107,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
343,1469,1,1,,8139882,5281855,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
344,1469,1,1,,26748644,5281855,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
345,1469,1,1,,26753737,5281855,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
346,1471,2,1,,11113162,5281855,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
347,1471,2,1,,26748644,5281855,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
348,1471,2,1,,26753737,5281855,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
349,1476,2,1,,8139882,5281855,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
350,1476,2,1,,26748644,5281855,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
351,1476,2,1,,26753737,5281855,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
352,1478,2,1,,8139882,5281855,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
353,1478,2,1,,26748644,5281855,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
354,1478,2,1,,26753737,5281855,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
355,1479,1,2,,8139882,5281855,Inconclusive,189491771.0,7068.0,39.8107,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
356,1479,1,2,,26748644,5281855,Inconclusive,189491771.0,7068.0,25.1189,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
357,1479,1,2,,26753737,5281855,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
358,1481,1,2,,8139882,5281855,Inactive,111305821.0,7415.0,,,Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition,Screening,,
359,1486,1,3,,8139882,5281855,Inactive,,,,,Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability.,Screening,,
360,1487,1,1,,8139882,5281855,Inconclusive,27436948.0,4000.0,3.9811,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
361,1487,1,1,,26748644,5281855,Inactive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
362,1490,2,1,,8139882,5281855,Inconclusive,10954339.0,,79.4328,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
363,1490,2,1,,26748644,5281855,Inconclusive,10954339.0,,79.4328,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
364,1490,2,1,,26753737,5281855,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
365,1496,1,4,,8139882,5281855,Inactive,13124881.0,865.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
366,1496,1,4,,8139882,5281855,Inactive,19923198.0,861.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
367,1504,1,4,,8139882,5281855,Active,34190601.0,2775.0,,,Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions.,Summary,,
368,1509,1,2,,8139882,5281855,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
369,1510,1,3,,8139882,5281855,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
370,1515,1,2,,8139882,5281855,Inactive,24119166.0,10741.0,,,Primary biochemical high throughput screening assay to identify inhibitors of Retinoblastoma binding protein 9 (RBBP9),Screening,,
371,1519,1,3,,26748644,5281855,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
372,1519,1,3,,26753737,5281855,Inconclusive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
373,1527,1,3,,8139882,5281855,Inactive,7381449.0,14678525.0,,,Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase,Screening,,
374,1529,1,1,,8139882,5281855,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
375,1530,1,1,,8139882,5281855,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
376,1531,1,1,,8139882,5281855,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
377,1549,1,2,,11537684,5281855,Inactive,89033149.0,,,,NMR Based Screening Assay for Novel Chemotypes against influenza A virus,Other,,
378,1552,1,3,,11537684,5281855,Inactive,4507793.0,7334.0,,,NMR assay targeting the ubiquitin-proteasome system to modulate protein folding and degradation,Other,,
379,1556,1,4,,8139882,5281855,Active,27368096.0,,,,Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase,Screening,,
380,1565,2,2,,8139882,5281855,Inactive,219689097.0,162466.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit PHOSPHO1,Confirmatory,,
381,1566,2,3,,8139882,5281855,Inactive,11545912.0,64127.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD2,Confirmatory,,
382,1578,3,2,,8139882,5281855,Inactive,5174617.0,10392.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD1,Confirmatory,,
383,1619,1,2,,8139882,5281855,Active,124809582.0,812021.0,138.08,IC50,Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP),Confirmatory,,
384,1631,3,1,,8139882,5281855,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
385,1634,3,1,,8139882,5281855,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
386,1637,1,2,,11537684,5281855,Inactive,,,,,NMR Based Screening Assay for Influenza A RNA Promoter,Other,,
387,1648,1,2,,11537684,5281855,Inactive,159164579.0,,,,NMR Based Screening Assay For Novel Chemical Probes Targeting The FRB Domain of mTOR,Other,,
388,1654,2,2,,8139882,5281855,Inactive,4758208.0,1845.0,0.98,IC50,uHTS absorbance assay for the identification of compounds that inhibit VHR1.,Confirmatory,,
389,1656,2,2,,8139882,5281855,Inactive,,,,,High Throughput Imaging Assay for Hepatic Lipid Droplet Formation,Screening,,
390,1688,1,1,,8139882,5281855,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
391,1688,1,1,,26748644,5281855,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
392,1700,1,2,,8139882,5281855,Inactive,124263658.0,688.0,,,Primary cell-based high throughput screening assay to identify inhibitors of kruppel-like factor 5 (KLF5),Screening,,
393,1706,1,2,,8139882,5281855,Inactive,73745819.0,,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro),Screening,,
394,1721,1,2,,8139882,5281855,Inactive,290753097.0,,,Potency,qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
395,1722,1,2,,8139882,5281855,Inactive,290753097.0,,,Potency,qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
396,1775,1,2,,8139882,5281855,Inactive,,,,,Profiling compound fluorescence on Avidin Beads with 488 nm excitation and 530 nm emission,Other,,
397,1776,1,2,,8139882,5281855,Inactive,,,,,Profiling compound fluorescence on GSH Beads with 488 nm excitation and 530 nm emission,Other,,
398,1777,3,2,,8139882,5281855,Inactive,39725940.0,4986.0,,EC50,uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
399,1778,3,3,,8139882,5281855,Inactive,39725940.0,4986.0,,IC50,uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
400,1779,2,2,,8139882,5281855,Inactive,224586929.0,26191.0,,IC50,uHTS identification of small molecule inhibitors of LYP via a fluorescence intensity assay,Confirmatory,,
401,1789,1,2,,8139882,5281855,Inactive,83318444.0,3320.0,,,Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90),Screening,,
402,1800,1,2,,8139882,5281855,Inactive,125541954.0,,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3),Screening,,
403,1817,2,2,,8139882,5281855,Inactive,40849930.0,5339.0,,IC50,uHTS identification of small molecule antagonists of the binding of Siah-1 and a peptide ligand via a fluorescence polarization assay.,Confirmatory,,
404,1822,1,3,,8139882,5281855,Active,23505220.0,813594.0,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP).,Screening,,
405,1825,1,1,,8139882,5281855,Inactive,,,,,Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line.,Screening,,
406,1845,1,2,,8139882,5281855,Inactive,125541954.0,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID),Screening,,
407,1850,2,1,,8139882,5281855,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
408,1861,2,1,,8139882,5281855,Inactive,119607128.0,2831.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7).,Screening,,
409,1863,2,1,,8139882,5281855,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
410,1865,1,1,,8139882,5281855,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
411,1865,1,1,,26748644,5281855,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
412,1865,1,1,,26753737,5281855,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
413,1878,1,2,,8139882,5281855,Inactive,4758208.0,1845.0,1.23,IC50,Fluorescent assay for identification of compounds that inhibit VHR1,Confirmatory,,
414,1899,1,3,,8139882,5281855,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
415,1903,2,3,,8139882,5281855,Inconclusive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
416,1906,1,3,,8139882,5281855,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
417,1947,1,2,,8139882,5281855,Active,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
418,1948,1,1,,26748644,5281855,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
419,1948,1,1,,26753737,5281855,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
420,1950,1,3,,8139882,5281855,Active,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
421,1961,2,2,,8139882,5281855,Inactive,33695107.0,9290.0,,EC50,Image-based HTS for Selective Agonists of GPR55,Confirmatory,,
422,1962,1,2,,8139882,5281855,Active,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
423,1974,1,2,,8139882,5281855,Active,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
424,1978,1,2,,8139882,5281855,Active,21595511.0,226016.0,,,Fluorescence polarization-based confirmation biochemical high throughput screening assay for inhibitors of the serine hydrolase family member Fam108b.,Screening,,
425,1984,1,3,,8139882,5281855,Inactive,118026946.0,17979.0,,IC50,Fluorescence for the identification of compounds that decrease p/CIP protein stability,Confirmatory,,
426,1986,1,2,,8139882,5281855,Active,45357394.0,,,IC50,uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors.,Confirmatory,,
427,1987,1,2,,8139882,5281855,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
428,2006,3,2,,8139882,5281855,Inconclusive,4507785.0,7329.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
429,2006,3,2,,8139882,5281855,Inconclusive,13111961.0,10054.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
430,2006,3,2,,8139882,5281855,Inconclusive,17390638.0,10055.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
431,2012,3,2,,8139882,5281855,Inactive,45219878.0,7458.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H),Confirmatory,,
432,2013,2,2,,8139882,5281855,Inactive,33695107.0,9290.0,,IC50,Image-Based HTS for Selective Antagonists for GPR55,Confirmatory,,
433,2014,3,2,,8139882,5281855,Inactive,46367787.0,26986.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP),Confirmatory,,
434,2016,1,3,,8139882,5281855,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
435,2023,1,3,,8139882,5281855,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
436,2025,1,3,,8139882,5281855,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
437,2029,1,3,,8139882,5281855,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
438,2052,2,1,,8139882,5281855,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
439,2057,1,2,,8139882,5281855,Active,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
440,2058,3,2,,8139882,5281855,Inactive,33695097.0,2859.0,,IC50,Image-Based HTS for Selective Antagonists of GPR35,Confirmatory,,
441,2066,1,4,,8139882,5281855,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
442,2071,2,2,,8139882,5281855,Inactive,14719829.0,22861.0,,,Colorimetric  Assay for Inhibitors for NALP1,Screening,,
443,2073,2,3,,8139882,5281855,Inactive,2625023.0,83589.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
444,2073,2,3,,8139882,5281855,Inactive,4502523.0,774.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
445,2100,1,1,,8139882,5281855,Inconclusive,119393891.0,2548.0,4.4668,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen,Confirmatory,,
446,2101,1,1,,8139882,5281855,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
447,2101,1,1,,26748644,5281855,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
448,2101,1,1,,26753737,5281855,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
449,2107,1,1,,8139882,5281855,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
450,2107,1,1,,26748644,5281855,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
451,2107,1,1,,26753737,5281855,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
452,2112,1,1,,8139882,5281855,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
453,2112,1,1,,26748644,5281855,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
454,2112,1,1,,26753737,5281855,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
455,2129,1,2,,8139882,5281855,Active,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
456,2130,1,3,,8139882,5281855,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
457,2147,1,1,,8139882,5281855,Active,221046486.0,,2.5119,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
458,2147,1,1,,26748644,5281855,Active,221046486.0,,0.7943,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
459,2147,1,1,,26753737,5281855,Active,221046486.0,,7.0795,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
460,2149,1,2,,8139882,5281855,Active,68476498.0,,,,Fluorescence polarization-based biochemical high throughput confirmation assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
461,2153,1,2,,8139882,5281855,Inactive,83774548.0,5997907.0,,,Fluorescence polarization-based counterscreen assay for inhibitors of tRNA 2'-phosphotransferase (TPT1): biochemical high throughput screening assay to identify inhibitors of RNAse T1.,Screening,,
462,2160,2,1,,8139882,5281855,Active,68476498.0,,0.54068,IC50,Fluorescence polarization-based biochemical high throughput dose response assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Confirmatory,,
463,2166,1,2,,8139882,5281855,Active,20336335.0,598.0,,,"Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
464,2167,1,2,,8139882,5281855,Inactive,83774548.0,5997907.0,55.688,IC50,Counterscreen for inhibitors of tRNA 2'-phosphotransferase (TPT1): fluorescence polarization-based biochemical high throughput dose response assay to identify inhibitors of RNAse T1.,Confirmatory,,
465,2168,1,2,,8139882,5281855,Active,78070770.0,4170.0,,,Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
466,2174,1,3,,8139882,5281855,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
467,2177,1,3,,8139882,5281855,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
468,2205,1,1,,8139882,5281855,Inactive,29788785.0,203068.0,,,HCS assay for microtubule stabilizers,Screening,,
469,2234,1,2,,8139882,5281855,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
470,2235,1,2,,8139882,5281855,Active,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
471,2242,1,1,,8139882,5281855,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
472,2280,2,3,,8139882,5281855,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
473,2288,1,1,,8139882,5281855,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/orActivators of miR-21,Confirmatory,,
474,2289,1,1,,8139882,5281855,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21,Confirmatory,,
475,2292,1,2,,8139882,5281855,Active,23893623.0,3783709.0,,,Fluorescence polarization-based biochemical high throughput confirmation assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
476,2300,1,3,,8139882,5281855,Active,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
477,2314,1,2,,8139882,5281855,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
478,2314,1,2,,8139882,5281855,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
479,2315,1,2,,8139882,5281855,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
480,2315,1,2,,8139882,5281855,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
481,2326,1,1,,8139882,5281855,Inactive,194352380.0,,,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
482,2328,1,2,,8139882,5281855,Active,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput assay for inhibitors of the Epstein-Barr virus-encoded protein, ZTA, in triplicate.",Screening,,
483,2379,1,2,,8139882,5281855,Active,216409728.0,10002.0,,,"TR-FRET-based biochemical high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
484,2391,1,1,,8139882,5281855,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
485,2417,1,1,,8139882,5281855,Inconclusive,4506243.0,5725.0,,,High Content Assay for Compounds that inhibit the Assembly of the Perinucleolar Compartment,Screening,,
486,2435,1,2,,8139882,5281855,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
487,2445,1,2,,8139882,5281855,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
488,2451,1,2,,8139882,5281855,Active,122920737.0,,1.9905,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
489,2451,1,2,,26748644,5281855,Active,122920737.0,,3.9716,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
490,2451,1,2,,26753737,5281855,Active,122920737.0,,19.9054,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
491,2462,1,1,,8139882,5281855,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
492,2462,1,1,,8139882,5281855,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
493,2472,1,2,,8139882,5281855,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
494,2472,1,2,,26748644,5281855,Active,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
495,2472,1,2,,26753737,5281855,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
496,2517,2,1,,8139882,5281855,Active,6980812.0,,0.0447,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
497,2517,2,1,,26748644,5281855,Active,6980812.0,,0.0112,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
498,2517,2,1,,26753737,5281855,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
499,2528,1,2,,8139882,5281855,Active,4557365.0,641.0,1.9953,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
500,2528,1,2,,26748644,5281855,Active,4557365.0,641.0,1.122,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
501,2528,1,2,,26753737,5281855,Active,4557365.0,641.0,15.8489,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
502,2546,1,1,,8139882,5281855,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
503,2546,1,1,,26748644,5281855,Inconclusive,188536040.0,19885.0,35.4813,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
504,2546,1,1,,26753737,5281855,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
505,2549,1,1,,8139882,5281855,Active,282403581.0,,0.5623,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
506,2549,1,1,,26748644,5281855,Active,282403581.0,,0.1259,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
507,2549,1,1,,26753737,5281855,Inconclusive,282403581.0,,3.9811,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
508,2551,1,1,,8139882,5281855,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
509,2551,1,1,,26748644,5281855,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
510,2551,1,1,,26753737,5281855,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
511,2557,1,3,,8139882,5281855,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
512,2564,1,1,,26748644,5281855,Active,,,0.0891,Potency,Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Assay,Confirmatory,,
513,2565,1,1,,26748644,5281855,Inconclusive,405898.0,,19.9526,Potency,Counterscreen for APE1 Inhibitors: qHTS Assay for Inhibitors of Endonuclease IV,Confirmatory,,
514,2572,1,1,,26748644,5281855,Active,6980812.0,,0.0141,Potency,Confirmation qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
515,2573,1,1,,26748644,5281855,Active,6980812.0,,28.1838,Potency,qHTS FP-Based Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
516,2606,1,2,,8139882,5281855,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
517,2629,1,1,,8139882,5281855,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
518,2650,2,1,,8139882,5281855,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
519,2661,1,1,,8139882,5281855,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
520,2662,2,1,,8139882,5281855,Inconclusive,56550039.0,4297.0,11.2202,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
521,2675,1,1,,8139882,5281855,Inconclusive,41281591.0,4154.0,79.4328,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
522,2676,1,2,,8139882,5281855,Inactive,85986601.0,59350.0,,Potency,qHTS Assay for Agonists of the Relaxin Receptor RXFP1,Confirmatory,,
523,2685,1,1,,8139882,5281855,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells,Confirmatory,,
524,2690,1,2,,8139882,5281855,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
525,2708,1,1,,26748644,5281855,Inconclusive,282403581.0,,0.2239,Potency,Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
526,2711,1,1,,26748644,5281855,Active,,,4.4668,Potency,Counterscreen for RECQ1 Inhibitors: ADP Fluorescence Polarization Displacement Assay,Confirmatory,,
527,2712,1,1,,26748644,5281855,Active,,,4.4668,Potency,Counterscreen for BLMA Inhibitors: ADP Fluorescence Polarization Displacement Assay,Confirmatory,,
528,2716,1,1,,8139882,5281855,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
529,2717,1,2,,8139882,5281855,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
530,2718,1,1,,8139882,5281855,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
531,2732,1,1,,8139882,5281855,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
532,2751,2,2,,8139882,5281855,Active,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
533,2778,1,2,,26748644,5281855,Inconclusive,18860839.0,4221.0,630.957,Potency,Confirmation of Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Confirmation in an HTRF (commercial TR-FRET) Assay using His-tagged menin and biotin-labeled MLL peptide,Confirmatory,,
534,2778,1,2,,26748644,5281855,Inconclusive,56550039.0,4297.0,630.957,Potency,Confirmation of Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Confirmation in an HTRF (commercial TR-FRET) Assay using His-tagged menin and biotin-labeled MLL peptide,Confirmatory,,
535,2782,1,2,,26748644,5281855,Inconclusive,18860839.0,4221.0,44.7744,Potency,Confirmation of Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
536,2782,1,2,,26748644,5281855,Inconclusive,56550039.0,4297.0,44.7744,Potency,Confirmation of Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
537,2783,1,2,,26748644,5281855,Inactive,18860839.0,4221.0,,Potency,Confirmation of Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
538,2783,1,2,,26748644,5281855,Inactive,56550039.0,4297.0,,Potency,Confirmation of Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
539,2785,1,1,,8139882,5281855,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Giardia lamblia growth inhibition",Confirmatory,,
540,2786,1,1,,8139882,5281855,Inactive,,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Mammalian cellular toxicity",Confirmatory,,
541,2787,1,1,,8139882,5281855,Inconclusive,122920737.0,,14.1254,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Primary screen confirmation",Confirmatory,,
542,2794,1,1,,8139882,5281855,Inconclusive,126722869.0,100009055.0,63.0957,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Rabbit FBPA Selectivity",Confirmatory,,
543,2795,1,1,,8139882,5281855,Inconclusive,7669492.0,2597.0,79.4328,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen confirmation",Confirmatory,,
544,2796,1,4,,8139882,5281855,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
545,2797,1,2,,8139882,5281855,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
546,2837,1,1,,87544482,5281855,Inactive,83774548.0,5997907.0,49.751000000000005,IC50,Late stage counterscreen results for the probe development effort to identify inhibitors of tRNA 2'-phosphotransferase (TPT1): fluorescence polarization-based biochemical dose response assay to identify inhibitors of RNAse T1,Confirmatory,,
547,2838,1,1,,87544482,5281855,Active,68476498.0,,0.04187,IC50,Late stage results for the probe development effort to identify inhibitors of tRNA 2'-phosphotransferase (TPT1): Fluorescence polarization-based biochemical dose response assay for TPT1 inhibitors,Confirmatory,,
548,17435,6,2,,103163815,5281855,Active,,,0.081,Ki,Reaction rate parameter value for phosphate with transfer with respect to ATP,Confirmatory,7518523.0,
549,17439,7,1,,103163815,5281855,Active,,,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,Other,7518523.0,
550,17452,6,2,,103163815,5281855,Unspecified,,,78.78,Km,Reaction rate parameter value for phosphate with transfer with respect to ATP,Confirmatory,7518523.0,
551,22400,4,3,,103163815,5281855,Unspecified,,,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,Other,7518523.0,
552,53321,6,5,,103163815,5281855,Unspecified,,,,,Inhibition of DNA gyrase supercoiling in Escherichia coli.,Other,9871636.0,
553,69799,6,3,,103163815,5281855,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli KL-16 in the absence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,Other,,
554,69800,6,3,,103163815,5281855,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli KL-16 in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,Other,,
555,69801,6,3,,103163815,5281855,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli-ss in the absence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,Other,,
556,69802,6,3,,103163815,5281855,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli-ss in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,Other,,
557,78545,6,5,,103163815,5281855,Unspecified,,,,,Concentration facilitating 50% of the maximum of the cleavable complex,Other,,
558,78696,6,6,,103163815,5281855,Unspecified,,,,,In vitro antibacterial activity was determined as inhibitory concentration causing 50% DNA-gyrase supercoiling inhibition (SCI),Other,,
559,91425,9,5,,103163815,5281855,Active,82312013.0,,5.1,IC50,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",Confirmatory,10841789.0,
560,164264,6,3,,103163815,5281855,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Pseudomonas maltophilia 1057 in the presence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,Other,,
561,164265,6,3,,103163815,5281855,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Pseudomonas maltophilia 1057 in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,Other,,
562,164783,9,2,,103163815,5281855,Active,,,0.6,IC50,In vitro inhibitory activity against protein kinase A,Confirmatory,7518523.0,
563,200878,6,3,,103163815,5281855,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Salmonella Typhimurium 701 in the absence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,Other,,
564,200879,6,3,,103163815,5281855,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Salmonella Typhimurium 701 in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,Other,,
565,205908,6,3,,103163815,5281855,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Staphylococcus epidermidis strain OC2603,Other,,
566,206159,6,3,,103163815,5281855,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Staphylococcus aureus strain OC6538,Other,,
567,219531,9,2,,103163815,5281855,Active,,,0.3,IC50,Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src,Confirmatory,7518523.0,
568,247402,8,1,,103163815,5281855,Active,,,0.01,GI50,Growth inhibitory activity against human cancer cell line in the NCI's anticancer drug screening program,Confirmatory,15743190.0,
569,262917,8,2,,103163815,5281855,Active,,,0.04,IC50,Inhibition of rat liver CK2,Confirmatory,16610779.0,
570,262918,8,2,,103163815,5281855,Active,,,13.0,IC50,Inhibition of rat liver CK1,Confirmatory,16610779.0,
571,262919,9,2,,103163815,5281855,Active,,,3.5,IC50,Inhibition of PKA,Confirmatory,16610779.0,
572,262920,9,5,,103163815,5281855,Active,20455502.0,2932.0,7.5,IC50,Inhibition of human recombinant GSK3-beta,Confirmatory,16610779.0,
573,262921,6,8,,103163815,5281855,Unspecified,3219996.0,1859.0,40.0,IC50,Inhibition of human recombinant DYRK1a,Confirmatory,16610779.0,
574,262922,6,8,,103163815,5281855,Unspecified,417209.0,315707.0,40.0,IC50,Inhibition of rat spleen CSK,Confirmatory,16610779.0,
575,262923,9,5,,103163815,5281855,Active,2507209.0,81515.0,2.9,IC50,Inhibition of rat spleen Lyn,Confirmatory,16610779.0,
576,262924,9,5,,103163815,5281855,Active,3219819.0,25155.0,4.3,IC50,Inhibition of rat spleen SYK,Confirmatory,16610779.0,
577,262925,9,5,,103163815,5281855,Active,81885281.0,79113.0,9.4,IC50,Inhibition of rat spleen FGR,Confirmatory,16610779.0,
578,262926,6,8,,103163815,5281855,Unspecified,114762.0,4869.0,40.0,IC50,Inhibition of NPM-ALK,Confirmatory,16610779.0,
579,262926,6,8,,103163815,5281855,Unspecified,296439447.0,238.0,40.0,IC50,Inhibition of NPM-ALK,Confirmatory,16610779.0,
580,262927,6,8,,103163815,5281855,Unspecified,547807.0,5979.0,40.0,IC50,Inhibition of RET,Confirmatory,16610779.0,
581,262928,6,8,,103163815,5281855,Unspecified,156630887.0,2322.0,40.0,IC50,Inhibition of FLT3,Confirmatory,16610779.0,
582,262929,3,6,,103163815,5281855,Unspecified,,,,,Antiproliferative activity against SUDHL1 expressing NPM-ALK by MTT assay,Other,16610779.0,
583,262930,3,4,,103163815,5281855,Unspecified,,,,,Antiproliferative activity against FEPD by MTT assay,Other,16610779.0,
584,262931,3,6,,103163815,5281855,Unspecified,,,,,Antiproliferative activity against KARPAS299 expressing NPM-ALK by MTT assay,Other,16610779.0,
585,262932,3,6,,103163815,5281855,Unspecified,,,,,Antiproliferative activity against SR786 expressing NPM-ALK by MTT assay,Other,16610779.0,
586,264487,3,4,,103163815,5281855,Unspecified,,,,,[1-3H]-2-deoxy-D-glucose uptake in 3T3 L1 adipocytes,Other,16640344.0,
587,284121,6,2,,103163815,5281855,Inactive,,,,EC50,Antiamyloidogenic activity assessed as inhibition of beta amyloid (25-35) fibril formation after 6 hrs,Confirmatory,17049256.0,
588,310941,6,2,,103163815,5281855,Active,,,5.1,IC50,Inhibition of HIV1 integrase,Confirmatory,17367896.0,
589,317243,6,2,,103163815,5281855,Active,,,0.04,IC50,Inhibition of CK2 in rat liver,Confirmatory,18251491.0,
590,318865,6,2,,103163815,5281855,Unspecified,,,146.0,IC50,Inhibition of beta-lactamase AmpC,Confirmatory,18333608.0,
591,318866,6,2,,103163815,5281855,Unspecified,,,600.0,IC50,Inhibition of beta-lactamase AmpC in presence of 0.1% Triton X-100,Confirmatory,18333608.0,
592,318867,8,1,,103163815,5281855,Unspecified,,,470.0,IC50,Inhibition of chymotrypsin,Confirmatory,18333608.0,
593,318868,6,2,,103163815,5281855,Unspecified,,,600.0,IC50,Inhibition of chymotrypsin in presence of 0.1% Triton X-100,Confirmatory,18333608.0,
594,318869,6,2,,103163815,5281855,Unspecified,,,55.0,IC50,Inhibition of malate dehydrogenase,Confirmatory,18333608.0,
595,318870,6,2,,103163815,5281855,Unspecified,,,106.0,IC50,Inhibition of malate dehydrogenase in presence of 0.1% Triton X-100,Confirmatory,18333608.0,
596,318871,11,1,,103163815,5281855,Unspecified,,,64.0,IC50,Inhibition of cruzain,Confirmatory,18333608.0,
597,318872,11,1,,103163815,5281855,Unspecified,,,220.0,IC50,Inhibition of cruzain in presence of 0.01% Triton X-100,Confirmatory,18333608.0,
598,334756,8,1,,103163815,5281855,Active,,,0.21,IC50,Inhibition of H(+)/K(+) ATPase from pig gastric mucosa,Confirmatory,1324983.0,
599,334758,3,4,,103163815,5281855,Active,,,,,Inhibition of H(+)/K(+) ATPase from pig gastric mucosa by competitive-double reciprocal plot in presence of ATP,Other,1324983.0,
600,334759,3,4,,103163815,5281855,Active,,,,,Inhibition of H(+)/K(+) ATPase from pig gastric mucosa by non competitive-double reciprocal plot in presence of K+,Other,1324983.0,
601,335705,3,5,,103163815,5281855,Active,,,,,Anticarcinogenic activity in A/J mouse assessed as inhibition of Benzo(a)pyrene-induced tumorigenesis at 0.4 g/kg in diet for 21 days by mouse lung tumor inhibition study,Other,1453178.0,
602,338980,12,1,,103163815,5281855,Unspecified,,,5000.0,IC50,Inhibition of ACE by fluorometric assay,Confirmatory,3379417.0,
603,352791,6,2,,103163815,5281855,Active,,,0.02,Ki,Inhibition of rat liver CK2 by Lineweaver-Burke double reciprocal plot analysis,Confirmatory,19414254.0,
604,352792,6,2,,103163815,5281855,Active,,,0.04,IC50,Inhibition of rat liver CK2 catalytic activity,Confirmatory,19414254.0,
605,352793,6,2,,103163815,5281855,Active,,,2.0,IC50,Inhibition of PKA,Confirmatory,19414254.0,
606,352794,6,2,,103163815,5281855,Active,,,8.0,IC50,Inhibition of PKC,Confirmatory,19414254.0,
607,352795,9,5,,103163815,5281855,Active,55977123.0,1457.0,0.04,IC50,Inhibition of GST-fused human recombinant CK2alpha expressed in Escherichia coli HMS174 (DE3),Confirmatory,19414254.0,
608,355135,6,2,,103163815,5281855,Unspecified,,,,,Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 by disk diffusion method,Other,8904847.0,
609,355136,6,2,,103163815,5281855,Unspecified,,,,,Antimicrobial activity against Prevotella intermedia by disk diffusion method,Other,8904847.0,
610,355137,6,2,,103163815,5281855,Unspecified,,,,,Antimicrobial activity against Streptococcus mutans Ingbritt by disk diffusion method,Other,8904847.0,
611,355138,6,2,,103163815,5281855,Unspecified,,,,,Antimicrobial activity against Actinomyces viscosus W1053 by disk diffusion method,Other,8904847.0,
612,357253,6,2,,103163815,5281855,Unspecified,,,,,Inhibition of Saccharomyces cerevisiae fatty acid synthase,Other,12502337.0,
613,357254,6,2,,103163815,5281855,Unspecified,,,,,Antifungal activity against Candida albicans ATCC 90028,Other,12502337.0,
614,357255,6,2,,103163815,5281855,Unspecified,,,,,Antifungal activity against Cryptococcus neoformans ATCC 90113,Other,12502337.0,
615,357307,9,5,,103163815,5281855,Active,1706689.0,29230.0,2.0,IC50,Inhibition of C-terminal hexahistidine-tagged rat recombinant squalene epoxidase without N-terminal putative membrane domain expressed in Escherichia coli,Confirmatory,11520216.0,
616,357963,6,2,,103163815,5281855,Active,,,10.5,IC50,Inhibition of Candida albicans ATCC 10231 secreted aspartic protease,Confirmatory,11678651.0,
617,357964,6,2,,103163815,5281855,Active,,,37.1,IC50,Inhibition of pepsin,Confirmatory,11678651.0,
618,360324,8,2,,103163815,5281855,Unspecified,,,,,"Antiplasmodial activity after 24 hrs against chloroquine-sensitive, mefloquine-resistant Plasmodium falciparum D6 infected human erythrocytes by [G-3H]hypoxanthine uptake",Other,11374952.0,
619,360325,8,2,,103163815,5281855,Unspecified,,,,,"Antiplasmodial activity after 24 hrs against chloroquine-resistant, mefloquine-sensitive Plasmodium falciparum W2 infected human erythrocytes by [G-3H]hypoxanthine uptake",Other,11374952.0,
620,360326,4,3,,103163815,5281855,Unspecified,,,,,Cytotoxicity against HSF assessed as decrease in proliferation at 100 uM by MTT assay,Other,11374952.0,
621,360327,4,4,,103163815,5281855,Unspecified,,,,,Cytotoxicity against human HepG2 cells assessed as decrease in proliferation at 100 uM by MTT assay,Other,11374952.0,
622,397122,6,3,,103163815,5281855,Unspecified,,,,,Inhibition of HIV1 RT,Other,1710653.0,
623,400984,3,4,,103163815,5281855,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 0.1 uM,Other,2413172.0,
624,400985,3,4,,103163815,5281855,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 1 uM,Other,2413172.0,
625,400986,3,4,,103163815,5281855,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 10 uM,Other,2413172.0,
626,400987,3,4,,103163815,5281855,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 100 uM,Other,2413172.0,
627,400988,3,4,,103163815,5281855,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 1000 uM,Other,2413172.0,
628,400989,3,4,,103163815,5281855,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 0.1 uM,Other,2413172.0,
629,400990,3,4,,103163815,5281855,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 1 uM,Other,2413172.0,
630,400991,3,4,,103163815,5281855,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 10 uM,Other,2413172.0,
631,400992,3,4,,103163815,5281855,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 100 uM,Other,2413172.0,
632,400993,3,4,,103163815,5281855,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 1000 uM,Other,2413172.0,
633,434933,1,1,,87544482,5281855,Inactive,,,79.365,IC50,Late stage results for the probe development effort to identify inhibitors of tRNA 2'-phosphotransferase (TPT1): luminescence-based cell-based high throughput dose response assay to identify cytotoxic compounds using the HepG2 cell line,Confirmatory,,
634,434934,1,1,,87544482,5281855,Inactive,,,26.455,IC50,Late stage results for the probe development effort to identify inhibitors of tRNA 2'-phosphotransferase (TPT1): luminescence-based cell-based high throughput dose response assay to identify cytotoxic compounds using the 3T3 cell line,Confirmatory,,
635,434955,1,2,,8139882,5281855,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
636,434962,1,2,,8139882,5281855,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
637,434975,1,1,,87544482,5281855,Inactive,,,,,Late stage results for the probe development effort to identify inhibitors of tRNA 2'-phosphotransferase (TPT1): disc diffusion-based assay to identify compounds that inhibit Candida albicans growth,Other,,
638,434989,1,1,,8139882,5281855,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
639,435030,1,2,,8139882,5281855,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
640,435030,1,2,,8139882,5281855,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
641,436175,3,5,,103163815,5281855,Unspecified,,,,,Antiinflammatory activity in human neutrophils assessed as respiratory burst inhibition at 1000 ug/ml by WST-1 assay,Other,19006373.0,
642,449728,1,2,,8139882,5281855,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
643,449762,1,2,,8139882,5281855,Inactive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
644,462270,8,5,,103163815,5281855,Active,115449.0,759.0,2.32,Ki,Inhibition of human CA1 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
645,462271,8,5,,103163815,5281855,Active,115456.0,760.0,2.18,Ki,Inhibition of human CA2 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
646,462272,8,5,,103163815,5281855,Active,134047703.0,761.0,10.5,Ki,Inhibition of human CA3 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
647,462273,8,5,,103163815,5281855,Active,115465.0,762.0,9.08,Ki,Inhibition of human CA4 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
648,462274,8,5,,103163815,5281855,Active,461680.0,763.0,7.59,Ki,Inhibition of human CA5A by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
649,462275,8,5,,103163815,5281855,Active,8928041.0,11238.0,12.7,Ki,Inhibition of human CA5B by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
650,462276,8,5,,103163815,5281855,Active,116241278.0,765.0,7.06,Ki,Inhibition of human CA6 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
651,462277,8,5,,103163815,5281855,Active,1168744.0,766.0,6.32,Ki,Inhibition of human CA7 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
652,462278,8,5,,103163815,5281855,Active,83300925.0,768.0,9.37,Ki,Inhibition of human CA9 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
653,462279,8,5,,103163815,5281855,Active,5915866.0,771.0,10.1,Ki,Inhibition of human CA12 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
654,462280,8,5,,103163815,5281855,Active,30580372.0,71934.0,10.3,Ki,Inhibition of mouse CA13 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
655,462281,8,5,,103163815,5281855,Active,8928036.0,23632.0,8.91,Ki,Inhibition of human CA14 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
656,463075,1,1,,8139882,5281855,Inactive,,,,,HTS to identify inhibitors of TNF-alpha Induced Cell Death in Jurkat FADD-/- Cells.,Screening,,
657,463079,1,2,,8139882,5281855,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
658,463082,1,1,,8139882,5281855,Active,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
659,463115,1,1,,8139882,5281855,Inactive,119622516.0,5045.0,,,High throughput fluorescence intensity-based biochemical assay to screen for small molecule inhibitors of Furin conducted by the Pittsburgh Molecular Library Screening Center.,Screening,,
660,463141,1,2,,8139882,5281855,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
661,463187,1,1,,8139882,5281855,Inactive,,,,,384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC,Screening,,
662,463193,1,1,,8139882,5281855,Inactive,31563518.0,84557.0,,,High-content cell-based screening for modulators of autophagy,Screening,,
663,463210,1,2,,8139882,5281855,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
664,463230,1,2,,8139882,5281855,Active,270133071.0,7941.0,,,Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7),Screening,,
665,463254,1,1,,8139882,5281855,Active,188528692.0,9099.0,1.122,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
666,475504,3,3,,103163815,5281855,Inactive,,,,,Binding affinity to amyloid beta (1 to 42) fibrils by change in fluorescence at 100 uM after 10 mins,Other,19640715.0,
667,475505,3,3,,103163815,5281855,Inactive,,,,,Binding affinity to amyloid beta (1 to 42) oligomers by change in fluorescence at 100 uM after 10 mins,Other,19640715.0,
668,485270,1,1,,8139882,5281855,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
669,485272,1,1,,8139882,5281855,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
670,485275,1,3,,8139882,5281855,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
671,485281,1,1,,8139882,5281855,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
672,485290,1,1,,8139882,5281855,Inconclusive,20150581.0,,0.0501,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
673,485290,1,1,,26748644,5281855,Active,20150581.0,,0.0708,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
674,485290,1,1,,26753737,5281855,Active,20150581.0,,0.1,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
675,485294,1,1,,8139882,5281855,Inconclusive,119389684.0,,56.2341,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
676,485297,1,1,,8139882,5281855,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
677,485298,1,1,,8139882,5281855,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
678,485313,1,2,,8139882,5281855,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
679,485314,1,1,,8139882,5281855,Active,4505931.0,5423.0,0.1585,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
680,485317,1,2,,8139882,5281855,Inactive,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
681,485341,1,1,,8139882,5281855,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
682,485344,1,1,,8139882,5281855,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists,Screening,,
683,485347,1,2,,8139882,5281855,Inactive,4503385.0,1813.0,,,HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators,Screening,,
684,485349,1,1,,8139882,5281855,Inconclusive,71902540.0,472.0,19.9526,Potency,qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia,Confirmatory,,
685,485350,1,2,,92124524,5281855,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
686,485353,2,1,,8139882,5281855,Active,30124074.0,1489680.0,,,qHTS of Yeast-based Assay for SARS-CoV PLP,Confirmatory,,
687,485358,1,1,,8139882,5281855,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists,Screening,,
688,485360,1,1,,8139882,5281855,Inconclusive,117938328.0,26013.0,,Potency,qHTS Assay for the Inhibitors of L3MBTL1,Confirmatory,,
689,485364,1,1,,8139882,5281855,Inactive,15149312.0,8345881.0,,Potency,qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins,Confirmatory,,
690,485367,1,2,,8139882,5281855,Inconclusive,72386991.0,3656265.0,16.9441,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
691,488837,1,1,,8139882,5281855,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
692,488839,1,1,,8139882,5281855,Inactive,20072248.0,8851.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
693,488839,1,1,,8139882,5281855,Inactive,48146199.0,1020.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
694,488847,1,3,,8139882,5281855,Active,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
695,488862,1,1,,8139882,5281855,Inactive,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
696,488890,1,2,,8139882,5281855,Inactive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
697,488895,1,2,,8139882,5281855,Inactive,90111653.0,948321.0,,,High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
698,488896,1,1,,8139882,5281855,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
699,488899,1,1,,8139882,5281855,Inactive,40807040.0,4286.0,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
700,488965,1,2,,8139882,5281855,Inactive,218891639.0,,,,Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
701,488966,1,1,,8139882,5281855,Inactive,,,,IC50,Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis,Confirmatory,,
702,488975,1,2,,8139882,5281855,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
703,488977,1,2,,8139882,5281855,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
704,489007,1,1,,26748644,5281855,Active,20150581.0,,0.004,Potency,Confirmation Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
705,492947,1,1,,8139882,5281855,Inactive,4501969.0,154.0,,Potency,qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
706,492953,1,1,,8139882,5281855,Active,296080766.0,5049.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2)",Screening,,
707,492956,1,1,,8139882,5281855,Active,4758878.0,5051.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2),Screening,,
708,492972,1,1,,8139882,5281855,Active,225543099.0,5050.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
709,493005,1,1,,8139882,5281855,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
710,493008,1,1,,8139882,5281855,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
711,493008,1,1,,8139882,5281855,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
712,493008,1,1,,8139882,5281855,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
713,493008,1,1,,8139882,5281855,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
714,493014,1,1,,8139882,5281855,Inactive,,,,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
715,493033,1,2,,92124524,5281855,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
716,493056,1,1,,8139882,5281855,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers,Screening,,
717,493084,1,1,,8139882,5281855,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists.,Screening,,
718,493087,1,1,,8139882,5281855,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE),Screening,,
719,493091,1,1,,8139882,5281855,Active,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
720,493098,1,1,,8139882,5281855,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
721,493131,1,1,,8139882,5281855,Inactive,6679827.0,14282.0,,,Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity,Screening,,
722,493160,1,1,,8139882,5281855,Active,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
723,493187,1,2,,8139882,5281855,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
724,493244,1,1,,8139882,5281855,Active,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
725,493244,1,1,,8139882,5281855,Active,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
726,493244,1,1,,8139882,5281855,Active,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
727,493244,1,1,,8139882,5281855,Active,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
728,504326,1,2,,8139882,5281855,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
729,504326,1,2,,8139882,5281855,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
730,504327,1,1,,8139882,5281855,Inconclusive,153791535.0,2648.0,25.1189,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
731,504329,1,1,,8139882,5281855,Inactive,227977143.0,23308111.0,,IC50,Discovery of Small Molecule Probes for H1N1 Influenza NS1A,Confirmatory,,
732,504332,1,1,,8139882,5281855,Active,168985070.0,,1.2589,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
733,504333,1,1,,8139882,5281855,Active,6683500.0,29994.0,0.7943,Potency,qHTS Assay for Inhibitors of BAZ2B,Confirmatory,,
734,504339,1,1,,8139882,5281855,Active,162330054.0,,0.7079,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
735,504357,1,1,,8139882,5281855,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
736,504357,1,1,,8139882,5281855,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
737,504370,1,1,,26748644,5281855,Inactive,13124873.0,865.0,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: ME-1 cellular proliferation,Confirmatory,,
738,504370,1,1,,26748644,5281855,Inactive,49574546.0,861.0,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: ME-1 cellular proliferation,Confirmatory,,
739,504374,2,1,,26748644,5281855,Active,13124873.0,865.0,0.1585,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation,Confirmatory,,
740,504374,2,1,,26748644,5281855,Active,49574546.0,861.0,0.1585,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation,Confirmatory,,
741,504375,1,2,,26748644,5281855,Inconclusive,13124873.0,865.0,0.5623,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay,Confirmatory,,
742,504375,1,2,,26748644,5281855,Inconclusive,49574546.0,861.0,0.5623,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay,Confirmatory,,
743,504406,1,1,,8139882,5281855,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
744,504411,1,1,,8139882,5281855,Inactive,218931251.0,221955.0,,,"Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB)",Screening,,
745,504414,1,1,,8139882,5281855,Inactive,9966877.0,57120.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
746,504414,1,1,,8139882,5281855,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
747,504423,1,1,,8139882,5281855,Active,312275222.0,,,,C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
748,504441,1,1,,8139882,5281855,Inactive,6978787.0,25255.0,,,Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
749,504444,1,1,,8139882,5281855,Inconclusive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
750,504454,1,3,,8139882,5281855,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method,Screening,,
751,504462,1,1,,8139882,5281855,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
752,504466,1,1,,8139882,5281855,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
753,504467,1,1,,8139882,5281855,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
754,504490,1,2,,8139882,5281855,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling,Screening,,
755,504523,1,1,,8139882,5281855,Inactive,45269145.0,9817.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
756,504523,1,1,,8139882,5281855,Inactive,224028257.0,4780.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
757,504558,1,1,,8139882,5281855,Inactive,23893668.0,3783750.0,,,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
758,504577,2,2,,8139882,5281855,Inactive,6325022.0,855842.0,,,HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
759,504582,2,1,,8139882,5281855,Active,124809271.0,811941.0,,,In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
760,504621,1,1,,8139882,5281855,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
761,504634,1,1,,8139882,5281855,Inactive,13236497.0,3361.0,,,Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
762,504648,1,1,,8139882,5281855,Inactive,,,,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
763,504651,1,1,,8139882,5281855,Inactive,4503383.0,1812.0,,,Potentiators of Human D1 Dopamine Receptor: qHTS,Screening,,
764,504652,1,1,,8139882,5281855,Inactive,4503383.0,1812.0,,,Antagonist of Human D 1 Dopamine Receptor: qHTS,Screening,,
765,504660,1,1,,8139882,5281855,Inactive,4503383.0,1812.0,,,Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS,Screening,,
766,504690,1,3,,8139882,5281855,Inactive,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
767,504692,2,2,,8139882,5281855,Inactive,13236497.0,3361.0,,,Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
768,504700,1,1,,8139882,5281855,Inactive,46909587.0,5567.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
769,504700,1,1,,8139882,5281855,Inactive,47132585.0,5577.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
770,504706,1,1,,8139882,5281855,Inactive,23491729.0,7157.0,,Potency,qHTS assay for re-activators of p53 using a Luc reporter,Confirmatory,,
771,504707,1,1,,8139882,5281855,Inactive,6755076.0,18749.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
772,504707,1,1,,8139882,5281855,Inactive,115496662.0,615074.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
773,504720,1,1,,8139882,5281855,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
774,504734,1,1,,8139882,5281855,Inactive,194068499.0,54106.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding.,Screening,,
775,504749,1,3,,26748644,5281855,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
776,504749,1,3,,104171339,5281855,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
777,504749,1,3,1.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
778,504749,1,3,2.0,104171339,5281855,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
779,504749,1,3,3.0,104171339,5281855,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
780,504749,1,3,4.0,26748644,5281855,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
781,504749,1,3,5.0,104171339,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
782,504749,1,3,6.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
783,504749,1,3,7.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
784,504749,1,3,8.0,26748644,5281855,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
785,504749,1,3,9.0,104171339,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
786,504749,1,3,10.0,26748644,5281855,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
787,504749,1,3,11.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
788,504749,1,3,12.0,104171339,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
789,504749,1,3,13.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
790,504749,1,3,14.0,104171339,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
791,504749,1,3,15.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
792,504749,1,3,16.0,26748644,5281855,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
793,504749,1,3,17.0,26748644,5281855,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
794,504749,1,3,18.0,26748644,5281855,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
795,504749,1,3,19.0,26748644,5281855,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
796,504749,1,3,20.0,104171339,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
797,504749,1,3,21.0,26748644,5281855,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
798,504749,1,3,22.0,104171339,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
799,504749,1,3,23.0,104171339,5281855,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
800,504749,1,3,24.0,26748644,5281855,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
801,504749,1,3,25.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
802,504749,1,3,26.0,26748644,5281855,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
803,504749,1,3,27.0,104171339,5281855,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
804,504749,1,3,28.0,104171339,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
805,504749,1,3,29.0,26748644,5281855,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
806,504749,1,3,30.0,104171339,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
807,504749,1,3,31.0,104171339,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
808,504749,1,3,32.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
809,504749,1,3,33.0,104171339,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
810,504749,1,3,34.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
811,504749,1,3,35.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
812,504749,1,3,36.0,104171339,5281855,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
813,504749,1,3,37.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
814,504749,1,3,38.0,104171339,5281855,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
815,504749,1,3,39.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
816,504749,1,3,40.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
817,504749,1,3,41.0,104171339,5281855,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
818,504749,1,3,42.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
819,504749,1,3,43.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
820,504749,1,3,44.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
821,504749,1,3,45.0,104171339,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
822,504749,1,3,46.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
823,504749,1,3,47.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
824,504749,1,3,48.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
825,504749,1,3,49.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
826,504749,1,3,50.0,104171339,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
827,504749,1,3,51.0,26748644,5281855,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
828,504749,1,3,52.0,26748644,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
829,504749,1,3,53.0,104171339,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
830,504749,1,3,54.0,26748644,5281855,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
831,504749,1,3,55.0,104171339,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
832,504749,1,3,56.0,26748644,5281855,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
833,504749,1,3,57.0,26748644,5281855,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
834,504749,1,3,58.0,26748644,5281855,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
835,504749,1,3,59.0,104171339,5281855,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
836,504749,1,3,60.0,104171339,5281855,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
837,504749,1,3,61.0,26748644,5281855,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
838,504766,2,1,,8139882,5281855,Inactive,5016090.0,190.0,,,"Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1)",Screening,,
839,504770,1,2,,92124524,5281855,Inactive,9657380.0,2612528.0,,,A screen for compounds that inhibit replication of Vibrio cholerae chromosome II,Other,,
840,504775,1,1,,8139882,5281855,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity,Screening,,
841,504787,1,1,,8139882,5281855,Inactive,20336229.0,5468.0,,,"Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): TR-FRET-based biochemical high throughput assay to identify agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2)",Screening,16834531.0,
842,504787,1,1,,8139882,5281855,Inactive,331284176.0,9612.0,,,"Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): TR-FRET-based biochemical high throughput assay to identify agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2)",Screening,16834531.0,
843,504803,1,1,,8139882,5281855,Inactive,121945198.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1),Screening,,
844,504810,1,2,,8139882,5281855,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
845,504812,1,2,,8139882,5281855,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
846,504832,1,1,,8139882,5281855,Active,,,5.2213,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
847,504832,1,1,,104171339,5281855,Active,,,3.0131,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
848,504834,1,1,,8139882,5281855,Active,,,3.6964,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
849,504834,1,1,,104171339,5281855,Active,,,3.3808,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
850,504842,1,1,,8139882,5281855,Inactive,4090929.0,10576.0,,Potency,Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS,Confirmatory,,
851,504845,1,1,,8139882,5281855,Inconclusive,86301163.0,5999.0,79.4328,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
852,504847,1,1,,8139882,5281855,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
853,504847,1,1,,104171339,5281855,Active,63054845.0,7421.0,39.8107,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
854,504865,1,1,,104171339,5281855,Inconclusive,118600387.0,7398.0,56.2341,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
855,504884,1,2,,8139882,5281855,Inactive,115347926.0,1175052.0,,,Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
856,504891,1,1,,8139882,5281855,Inconclusive,5453898.0,5300.0,1.2589,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
857,504894,1,1,,8139882,5281855,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
858,504937,1,2,,8139882,5281855,Inactive,179095.0,6609.0,,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
859,540253,1,1,,8139882,5281855,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
860,540253,1,1,,8139882,5281855,Inactive,5453555.0,5901.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
861,540253,1,1,,8139882,5281855,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
862,540256,1,2,,8139882,5281855,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
863,540256,1,2,,104171339,5281855,Inconclusive,,,1.1175,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
864,540263,1,1,,8139882,5281855,Inconclusive,5031833.0,10073.0,15.8489,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
865,540263,1,1,,8139882,5281855,Inconclusive,19923142.0,3837.0,15.8489,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
866,540267,1,1,,8139882,5281855,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
867,540275,1,1,,8139882,5281855,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1,Screening,,
868,540276,1,2,,8139882,5281855,Active,420597.0,,4.1095,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
869,540276,1,2,,11113162,5281855,Active,420597.0,,0.996,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
870,540276,1,2,,26748644,5281855,Active,420597.0,,0.996,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
871,540276,1,2,,26748645,5281855,Active,420597.0,,0.996,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
872,540276,1,2,,26753737,5281855,Active,420597.0,,0.996,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
873,540276,1,2,,50123014,5281855,Active,420597.0,,0.996,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
874,540276,1,2,,104171339,5281855,Active,420597.0,,0.996,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
875,540277,1,1,,8139882,5281855,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1,Screening,,
876,540295,1,1,,8139882,5281855,Inactive,119508433.0,4160.0,,,TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R,Screening,,
877,540299,1,2,,92124524,5281855,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
878,540303,1,1,,8139882,5281855,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
879,540303,1,1,,8139882,5281855,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
880,540303,1,1,,8139882,5281855,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
881,540308,1,1,,8139882,5281855,Inactive,119508433.0,4160.0,,,Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R,Screening,,
882,540317,1,1,,8139882,5281855,Inconclusive,187960037.0,10951.0,1.0,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
883,540336,1,1,,8139882,5281855,Inactive,68474550.0,3639678.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
884,540336,1,1,,8139882,5281855,Inactive,68488893.0,3646682.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
885,540364,1,2,,8139882,5281855,Inactive,,2395.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter,Screening,,
886,544213,2,3,,103163815,5281855,Active,,,0.33,IC50,Antiplasmodial activity against Plasmodium falciparum F32,Confirmatory,19015354.0,
887,544214,2,4,,103163815,5281855,Active,,,0.105,IC50,Antiplasmodial activity against Plasmodium falciparum Dd2,Confirmatory,19015354.0,
888,544215,2,3,,103163815,5281855,Active,,,0.3,IC50,Antiplasmodial activity against Plasmodium falciparum FcB1,Confirmatory,19015354.0,
889,544216,2,3,,103163815,5281855,Active,,,0.33,IC50,Antiplasmodial activity against Plasmodium falciparum W2,Confirmatory,19015354.0,
890,544217,2,3,,103163815,5281855,Active,,,0.18,IC50,Antiplasmodial activity against Plasmodium falciparum FcM29,Confirmatory,19015354.0,
891,544218,1,4,,103163815,5281855,Unspecified,,,,,Cytotoxicity against Vero cells at 100 uM by MTS assay,Other,19015354.0,
892,544219,1,4,,103163815,5281855,Unspecified,,,,,Cytotoxicity against human MRC5 cells at 100 uM by MTS assay,Other,19015354.0,
893,544220,1,4,,103163815,5281855,Unspecified,,,,,Cytotoxicity against human KB cells at 100 uM by MTS assay,Other,19015354.0,
894,544221,2,3,,103163815,5281855,Unspecified,,,,,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 in presence of chloroquine,Other,19015354.0,
895,544222,1,3,,103163815,5281855,Unspecified,,,,,"Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as inhibition of parasite growth at 50 mg/kg/day, ip measured on day 4 postinfection",Other,19015354.0,
896,544223,1,3,,103163815,5281855,Unspecified,,,,,"Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as inhibition of parasite growth at 100 mg/kg/day, ip measured on day 5 postinfection",Other,19015354.0,
897,544224,1,3,,103163815,5281855,Active,,,,,"Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as inhibition of parasite growth at 1 mg/kg/day, po measured on day 4 postinfection",Other,19015354.0,
898,544225,1,3,,103163815,5281855,Active,,,,,"Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as inhibition of parasite growth at 50 mg/kg/day, po measured on day 4 postinfection",Other,19015354.0,
899,544226,1,3,,103163815,5281855,Active,,,,,"Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as inhibition of parasite growth at 100 mg/kg/day, po measured on day 5 postinfection",Other,19015354.0,
900,544227,1,3,,103163815,5281855,Active,,,,,"Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as recrudescence of malaria at 50 mg/kg/day, ip measured upto day 60 postinfection",Other,19015354.0,
901,544228,1,3,,103163815,5281855,Active,,,,,"Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as recrudescence of malaria at 100 mg/kg/day, ip measured upto day 60 postinfection",Other,19015354.0,
902,544229,1,3,,103163815,5281855,Active,,,,,"Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as recrudescence of malaria at 5 mg/kg/day, ip measured upto day 60 postinfection",Other,19015354.0,
903,544230,1,3,,103163815,5281855,Active,,,,,"Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as survival at 10 mg/kg, ip treated 4 days before infection measured on day 6 postinfection",Other,19015354.0,
904,544231,1,3,,103163815,5281855,Inactive,,,,,"Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as mortality at 100 mg/kg, po treated 4 days after infection measured on day 7 postinfection",Other,19015354.0,
905,544232,1,3,,103163815,5281855,Active,,,,,"Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as survival at 10 mg/kg, ip treated 4 days before infection measured on day 9 postinfection",Other,19015354.0,
906,544233,2,3,,103163815,5281855,Unspecified,,,,,"Toxicity in Swiss mouse at 100 mg/kg/day, po for 4 days measured upto day 30",Other,19015354.0,
907,544234,2,3,,103163815,5281855,Unspecified,,,,,"Toxicity in Swiss mouse at 250 mg/kg/day, po for 4 days measured upto day 30",Other,19015354.0,
908,544235,2,3,,103163815,5281855,Unspecified,,,,,"Toxicity in Swiss mouse at 500 mg/kg/day, po for 4 days measured upto day 30",Other,19015354.0,
909,544236,2,3,,103163815,5281855,Unspecified,,,,,"Toxicity in Swiss mouse at 1000 mg/kg/day, po for 4 days measured upto day 30",Other,19015354.0,
910,544237,2,3,,103163815,5281855,Unspecified,,,,,"Toxicity in Swiss mouse at 100 mg/kg/day, ip for 4 days measured upto day 30",Other,19015354.0,
911,544238,2,3,,103163815,5281855,Unspecified,,,,,"Toxicity in Swiss mouse at 250 mg/kg/day, ip for 4 days measured upto day 30",Other,19015354.0,
912,544251,2,3,,103163815,5281855,Unspecified,,,,,"Toxicity in Swiss mouse at 500 mg/kg/day, ip for 4 days measured upto day 30",Other,19015354.0,
913,544252,2,3,,103163815,5281855,Unspecified,,,,,"Toxicity in Swiss mouse at 1000 mg/kg/day, ip for 4 days measured upto day 30",Other,19015354.0,
914,544253,2,3,,103163815,5281855,Inactive,,,,,Antiplasmodial activity against Plasmodium falciparum FcM29 assessed as inhibition of parasite growth at 180 nM in presence of 0.87 uM N-acetyl-L-cysteine,Other,19015354.0,
915,544254,2,3,,103163815,5281855,Active,,,,,Antioxidant activity in human Monocyte assessed as reduced in PMA-induced ROS production at 3.3 uM by chemiluminescence assay,Other,19015354.0,
916,544256,2,4,,103163815,5281855,Unspecified,,,,,Antiplasmodial activity against mefloquine-susceptible Plasmodium falciparum Dd2 assessed as 50% revertant concentration required for mefloquine resistant,Other,19015354.0,
917,544257,2,3,,103163815,5281855,Unspecified,,,,,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 in presence of mefloquine,Other,19015354.0,
918,544258,2,3,,103163815,5281855,Unspecified,,,,,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 in presence of artemisinin,Other,19015354.0,
919,544259,2,3,,103163815,5281855,Unspecified,,,,,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 in presence of artesunate,Other,19015354.0,
920,544260,2,3,,103163815,5281855,Unspecified,,,,,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 in presence of atovaquone,Other,19015354.0,
921,580669,7,5,,103163815,5281855,Unspecified,75017163.0,,74.4,IC50,Inhibition of Plasmodium falciparum glutathione S-transferase,Confirmatory,19015351.0,
922,580670,7,5,,103163815,5281855,Unspecified,121746.0,2950.0,77.1,IC50,Inhibition of human glutathione S-transferase P,Confirmatory,19015351.0,
923,580671,4,2,,103163815,5281855,Active,,,27.6,IC50,Inhibition of Plasmodium falciparum glutathione reductase by spectrophotometer,Confirmatory,19015351.0,
924,580672,8,5,,103163815,5281855,Active,14916998.0,2936.0,22.8,IC50,Inhibition of human glutathione reductase by spectrophotometer,Confirmatory,19015351.0,
925,580673,4,2,,103163815,5281855,Unspecified,,,66.7,IC50,Inhibition of Plasmodium falciparum thioredoxin reductase TrxR assay,Confirmatory,19015351.0,
926,580674,4,2,,103163815,5281855,Unspecified,,,78.3,IC50,Inhibition of human thioredoxin reductase,Confirmatory,19015351.0,
927,580675,4,2,,103163815,5281855,Unspecified,,,137.8,IC50,Inhibition of Plasmodium falciparum thioredoxin reductase by DTNB assay,Confirmatory,19015351.0,
928,580676,4,2,,103163815,5281855,Unspecified,,,275.3,IC50,Inhibition of human thioredoxin reductase by DTNB assay,Confirmatory,19015351.0,
929,580677,2,4,,103163815,5281855,Active,,,0.8190000000000001,IC50,Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7,Confirmatory,19015351.0,
930,580678,2,5,,103163815,5281855,Active,,,1.325,IC50,Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum HB3,Confirmatory,19015351.0,
931,580679,2,4,,103163815,5281855,Active,,,0.35100000000000003,IC50,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2,Confirmatory,19015351.0,
932,580680,2,3,,103163815,5281855,Active,,,0.97,IC50,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1,Confirmatory,19015351.0,
933,580681,1,3,,103163815,5281855,Unspecified,,,,,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of artemisinin,Other,19015351.0,
934,580682,1,3,,103163815,5281855,Unspecified,,,,,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of artemether,Other,19015351.0,
935,580683,1,3,,103163815,5281855,Unspecified,,,,,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of artesunate,Other,19015351.0,
936,580684,1,3,,103163815,5281855,Unspecified,,,,,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of amodiaquine,Other,19015351.0,
937,580685,1,3,,103163815,5281855,Unspecified,,,,,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of chloroquine,Other,19015351.0,
938,580686,1,3,,103163815,5281855,Unspecified,,,,,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of mefloquine,Other,19015351.0,
939,580687,1,3,,103163815,5281855,Unspecified,,,,,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of premaquine,Other,19015351.0,
940,580688,1,3,,103163815,5281855,Unspecified,,,,,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of quinine,Other,19015351.0,
941,580689,1,3,,103163815,5281855,Unspecified,,,,,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of pyrimethamine,Other,19015351.0,
942,580690,1,3,,103163815,5281855,Unspecified,,,,,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of methylene blue,Other,19015351.0,
943,580717,7,1,,103163815,5281855,Inconclusive,,,,IC50,Cytotoxicity against rat L6 cells,Confirmatory,19015351.0,
944,580792,1,4,,103163815,5281855,Unspecified,,,,,Effect on thioredoxin reductase expression in human A549 cells assessed as transcript level at 166 nM after 24 hrs by RT-qPCR analysis relative to untreated control,Other,19015351.0,
945,580793,1,4,,103163815,5281855,Unspecified,,,,,Effect on thioredoxin reductase expression in human A549 cells assessed as transcript level at 662 nM after 24 hrs by RT-qPCR analysis relative to untreated control,Other,19015351.0,
946,580798,1,4,,103163815,5281855,Unspecified,,,,,Effect on glutathione S-transferase expression in human A549 cells assessed as transcript level at 166 nM after 24 hrs by RT-qPCR analysis relative to untreated control,Other,19015351.0,
947,580799,1,4,,103163815,5281855,Unspecified,,,,,Effect on glutathione S-transferase expression in human A549 cells assessed as transcript level at 662 nM after 24 hrs by RT-qPCR analysis relative to untreated control,Other,19015351.0,
948,580804,1,4,,103163815,5281855,Unspecified,,,,,Effect on glutathione reductase expression in human A549 cells assessed as transcript level at 166 nM after 24 hrs by RT-qPCR analysis relative to untreated control,Other,19015351.0,
949,580805,1,4,,103163815,5281855,Unspecified,,,,,Effect on glutathione reductase expression in human A549 cells assessed as transcript level at 662 nM after 24 hrs by RT-qPCR analysis relative to untreated control,Other,19015351.0,
950,580810,1,4,,103163815,5281855,Unspecified,,,,,Effect on glutathione peroxidase expression in human A549 cells assessed as transcript level at 166 nM after 24 hrs by RT-qPCR analysis relative to untreated control,Other,19015351.0,
951,580811,1,4,,103163815,5281855,Unspecified,,,,,Effect on glutathione peroxidase expression in human A549 cells assessed as transcript level at 662 nM after 24 hrs by RT-qPCR analysis relative to untreated control,Other,19015351.0,
952,580816,2,4,,103163815,5281855,Unspecified,,,,,Inhibition of thioredoxin reductase in human A549 cells assessed as enzyme activity at 166 nM after 24 hrs by DTNB assay relative to untreated control,Other,19015351.0,
953,580817,2,4,,103163815,5281855,Unspecified,,,,,Inhibition of thioredoxin reductase in human A549 cells assessed as enzyme activity at 662 nM after 24 hrs by DTNB assay relative to untreated control,Other,19015351.0,
954,580822,2,4,,103163815,5281855,Unspecified,,,,,Inhibition of glutathione S-transferase in human A549 cells assessed as enzyme activity at 166 nM after 24 hrs relative to untreated control,Other,19015351.0,
955,580823,2,4,,103163815,5281855,Unspecified,,,,,Inhibition of glutathione S-transferase in human A549 cells assessed as enzyme activity at 662 nM after 24 hrs relative to untreated control,Other,19015351.0,
956,580828,2,11,,103163815,5281855,Unspecified,14916998.0,2936.0,,,Inhibition of glutathione reductase in human A549 cells assessed as enzyme activity at 166 nM after 24 hrs relative to untreated control,Other,19015351.0,
957,580829,2,11,,103163815,5281855,Unspecified,14916998.0,2936.0,,,Inhibition of glutathione reductase in human A549 cells assessed as enzyme activity at 662 nM after 24 hrs relative to untreated control,Other,19015351.0,
958,580834,2,4,,103163815,5281855,Unspecified,,,,,Inhibition of glutathione peroxidase in human A549 cells assessed as enzyme activity at 166 nM after 24 hrs relative to untreated control,Other,19015351.0,
959,580835,2,4,,103163815,5281855,Unspecified,,,,,Inhibition of glutathione peroxidase in human A549 cells assessed as enzyme activity at 662 nM after 24 hrs relative to untreated control,Other,19015351.0,
960,580840,3,3,,103163815,5281855,Active,,,,,Inhibition of heme aggregation at 25 uM,Other,19015351.0,
961,580841,4,2,,103163815,5281855,Active,,,1.2,IC50,Inhibition of heme aggregation,Confirmatory,19015351.0,
962,588334,1,1,,8139882,5281855,Inactive,,,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity,Screening,,
963,588335,1,1,,8139882,5281855,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts,Screening,,
964,588342,1,1,,8139882,5281855,Inconclusive,160794.0,,21.3313,Potency,qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project),Confirmatory,,
965,588352,1,2,,8139882,5281855,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
966,588354,1,1,,8139882,5281855,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1),Screening,,
967,588358,1,2,,8139882,5281855,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies,Screening,,
968,588379,1,2,,124882875,5281855,Inactive,13399304.0,60489.0,,Potency,qHTS for inhibitors of Vif-A3G interactions: Validation,Confirmatory,,
969,588391,1,1,,8139882,5281855,Inactive,14790033.0,5034.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
970,588405,1,1,,8139882,5281855,Inactive,78486550.0,171071.0,,,HTS Assay for Peg3 Promoter Inhibitors,Screening,,
971,588413,1,2,,8139882,5281855,Inactive,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
972,588436,1,1,,8139882,5281855,Inactive,,,,,"Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity",Screening,,
973,588453,1,1,,8139882,5281855,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
974,588453,1,1,,124882878,5281855,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
975,588456,1,1,,8139882,5281855,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
976,588456,1,1,,124882878,5281855,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
977,588458,1,1,,8139882,5281855,Active,4503351.0,1786.0,,,uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay,Screening,,
978,588473,1,1,,8139882,5281855,Inactive,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
979,588473,1,1,,8139882,5281855,Inactive,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
980,588475,1,2,,8139882,5281855,Inactive,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
981,588475,1,2,,8139882,5281855,Inactive,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
982,588489,1,1,,8139882,5281855,Inactive,46367787.0,26986.0,,,uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Screening,,
983,588492,1,1,,8139882,5281855,Inactive,,,,,uHTS identification of small molecule modulators of myocardial damage,Screening,,
984,588493,1,2,,8139882,5281855,Inactive,16306916.0,10213.0,,,uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay,Screening,,
985,588497,1,2,,8139882,5281855,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,16604538.0,
986,588497,1,2,,8139882,5281855,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20035615.0,
987,588497,1,2,,8139882,5281855,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20938917.0,
988,588499,1,3,,8139882,5281855,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,16604538.0,
989,588499,1,3,,8139882,5281855,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20035615.0,
990,588499,1,3,,8139882,5281855,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20938917.0,
991,588501,1,2,,8139882,5281855,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,16604538.0,
992,588501,1,2,,8139882,5281855,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20035615.0,
993,588501,1,2,,8139882,5281855,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20938917.0,
994,588511,1,2,,8139882,5281855,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
995,588519,1,2,,92124524,5281855,Active,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
996,588549,1,1,,8139882,5281855,Active,1781172.0,,,,Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
997,588579,1,1,,8139882,5281855,Active,7705344.0,51426.0,0.7943,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
998,588579,1,1,,104171339,5281855,Active,7705344.0,51426.0,0.1259,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
999,588579,1,1,,124882875,5281855,Active,7705344.0,51426.0,0.2512,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1000,588579,1,1,,124882878,5281855,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1001,588590,1,1,,8139882,5281855,Active,154350220.0,11201.0,1.122,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
1002,588590,1,1,,26748644,5281855,Active,154350220.0,11201.0,0.1,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
1003,588590,1,1,,124882878,5281855,Inactive,154350220.0,11201.0,,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
1004,588591,1,1,,8139882,5281855,Active,5729982.0,5429.0,0.7943,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
1005,588621,1,1,,8139882,5281855,Active,90652859.0,84867.0,,,uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay,Screening,,
1006,588627,1,1,,8139882,5281855,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
1007,588649,1,1,,113234651,5281855,Inactive,21595511.0,226016.0,,,Late stage assay provider results from the probe development effort to identify inhibitors of Fam108b: gel-based activity-based protein profiling (ABPP) assay to assess HTS hit compound inhibition and selectivity against a recombinant soluble form of Fam108b,Other,,
1008,588664,1,2,,8139882,5281855,Active,62362414.0,25.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
1009,588664,1,2,,8139882,5281855,Active,68989256.0,9610.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
1010,588674,1,2,,8139882,5281855,Inactive,,,,,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1011,588675,1,1,,8139882,5281855,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
1012,588676,1,1,,8139882,5281855,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
1013,588689,1,1,,8139882,5281855,Inactive,219689243.0,,,IC50,Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition,Confirmatory,,
1014,588692,2,1,,8139882,5281855,Inactive,,,,,Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1015,588726,1,2,,8139882,5281855,Inactive,15607504.0,886474.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
1016,588727,1,1,,8139882,5281855,Inactive,,,,IC50,"A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83",Confirmatory,,
1017,588795,1,1,,8139882,5281855,Active,4758356.0,2237.0,1.5849,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
1018,588795,1,1,,124882878,5281855,Inconclusive,4758356.0,2237.0,70.7946,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
1019,588814,1,3,,8139882,5281855,Inactive,37622910.0,1128.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)",Screening,,
1020,588819,1,4,,8139882,5281855,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).,Screening,,
1021,588834,2,1,,26748644,5281855,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
1022,588850,1,1,,8139882,5281855,Inactive,90421313.0,1080.0,,,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
1023,588852,1,3,,8139882,5281855,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1),Screening,,
1024,588855,1,1,,8139882,5281855,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
1025,588855,1,1,,124882878,5281855,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
1026,588856,1,1,,8139882,5281855,Inactive,,,6.3096,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
1027,588856,1,1,,124882878,5281855,Inactive,,,,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
1028,602123,1,1,,8139882,5281855,Inactive,16128424.0,945085.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
1029,602141,1,1,,8139882,5281855,Inactive,,,,,uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors,Screening,,
1030,602162,1,1,,8139882,5281855,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set,Screening,,
1031,602163,1,1,,8139882,5281855,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA),Screening,,
1032,602179,1,2,,8139882,5281855,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
1033,602229,1,1,,8139882,5281855,Inactive,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
1034,602233,1,1,,8139882,5281855,Active,115503961.0,4357161.0,0.8913,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
1035,602244,1,2,,8139882,5281855,Inactive,5730106.0,10663.0,,,uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay,Screening,,
1036,602247,1,2,,8139882,5281855,Inactive,,,,,Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
1037,602248,1,2,,8139882,5281855,Inactive,,,,,Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
1038,602250,1,2,,8139882,5281855,Inactive,,,,,Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line,Screening,,
1039,602252,1,1,,8139882,5281855,Inactive,62868213.0,57120.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1040,602252,1,1,,8139882,5281855,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1041,602261,1,1,,8139882,5281855,Active,41872631.0,2194.0,,,uHTS identification of small molecule inhibitors of  the thioesterase domain of fatty acid synthase via a fluorescence intensity assay,Screening,,
1042,602274,1,2,,8139882,5281855,Inactive,,,,,uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells,Screening,,
1043,602281,1,1,,8139882,5281855,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1044,602281,1,1,,8139882,5281855,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1045,602310,1,2,,8139882,5281855,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
1046,602310,1,2,,124882878,5281855,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
1047,602313,1,1,,8139882,5281855,Inactive,22907044.0,200316.0,,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
1048,602314,1,2,,92124524,5281855,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
1049,602329,1,1,,8139882,5281855,Inactive,216548193.0,8438.0,,,Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1050,602332,1,1,,8139882,5281855,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1051,602332,1,1,,104171339,5281855,Inconclusive,168984549.0,,22.3872,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1052,602332,1,1,,124882875,5281855,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1053,602332,1,1,,124882878,5281855,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1054,602340,1,2,,8139882,5281855,Inactive,,,,,HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity,Screening,,
1055,602342,2,1,,8139882,5281855,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1056,602346,1,1,,8139882,5281855,Inactive,9629361.0,155459.0,,,Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1057,602363,1,1,,8139882,5281855,Inactive,,,,,Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity,Screening,,
1058,602393,1,1,,8139882,5281855,Inactive,291463269.0,20586.0,,,Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1059,602396,1,2,,8139882,5281855,Inactive,4504343.0,2494.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
1060,602399,1,2,,8139882,5281855,Inactive,15927174.0,,,,uHTS identification of inhibitors of NadD in a Colorimetric assay,Screening,,
1061,602405,1,1,,8139882,5281855,Inactive,75495260.0,,,,PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1062,602410,1,1,,8139882,5281855,Inactive,11093520.0,3777.0,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3,Screening,,
1063,602429,1,1,,8139882,5281855,Active,1762973.0,7341.0,,,uHTS identification of SUMO1-mediated protein-protein interactions,Screening,,
1064,602438,1,1,,8139882,5281855,Inactive,160877737.0,,,,uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay,Screening,,
1065,602440,1,1,,8139882,5281855,Inactive,262118306.0,123228.0,,,uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8),Screening,,
1066,602449,1,2,,8139882,5281855,Inactive,,,,,uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay,Screening,,
1067,602481,1,1,,8139882,5281855,Inactive,378544807.0,,,,Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1068,616482,2,3,,103163815,5281855,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity,Other,21821414.0,
1069,623870,1,1,,8139882,5281855,Inactive,2702319.0,405.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1070,623870,1,1,,8139882,5281855,Inactive,5454102.0,10460.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1071,623877,1,1,,8139882,5281855,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A),Screening,,
1072,623901,1,1,,8139882,5281855,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity,Screening,,
1073,624030,1,2,,104171339,5281855,Active,160794.0,,36.1254,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
1074,624031,1,2,,104171339,5281855,Inactive,,,,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
1075,624032,1,2,,104171339,5281855,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
1076,624037,1,3,,8139882,5281855,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1077,624038,1,3,,8139882,5281855,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1078,624040,1,3,,8139882,5281855,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1079,624044,1,2,,104171339,5281855,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
1080,624125,1,4,,8139882,5281855,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1081,624126,1,3,,8139882,5281855,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1082,624127,1,2,,8139882,5281855,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1083,624168,1,1,,8139882,5281855,Inactive,47678551.0,9215.0,,,uHTS identification of small molecule activators of alpha dystroglycan glycosylation,Screening,,
1084,624169,1,1,,8139882,5281855,Inactive,27753985.0,15558.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
1085,624170,1,1,,8139882,5281855,Active,71051501.0,2744.0,2.8184,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
1086,624170,1,1,,104171339,5281855,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
1087,624171,1,1,,8139882,5281855,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
1088,624172,1,1,,8139882,5281855,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
1089,624172,1,1,,104171339,5281855,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
1090,624173,1,3,,8139882,5281855,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
1091,624173,1,3,,104171339,5281855,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
1092,624178,1,1,,8139882,5281855,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
1093,624178,1,1,,124882878,5281855,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
1094,624202,1,1,,8139882,5281855,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
1095,624202,1,1,,124882878,5281855,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
1096,624204,1,2,,8139882,5281855,Inactive,7657550.0,,,,"uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay",Screening,,
1097,624246,1,1,,8139882,5281855,Inactive,343478176.0,2078.0,,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
1098,624256,1,2,,8139882,5281855,Inactive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with MLPCN compound set,Screening,,
1099,624263,1,1,,8139882,5281855,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1100,624263,1,1,,8139882,5281855,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1101,624263,1,1,,124882878,5281855,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1102,624263,1,1,,124882878,5281855,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1103,624267,1,2,,8139882,5281855,Inactive,4506537.0,8767.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
1104,624267,1,2,,8139882,5281855,Inactive,119603173.0,64127.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
1105,624268,1,3,,8139882,5281855,Inactive,71746704.0,3662741.0,,,Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS),Screening,,
1106,624288,1,1,,8139882,5281855,Inactive,52000961.0,2778.0,,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
1107,624296,1,1,,8139882,5281855,Inactive,7705682.0,51053.0,0.0046,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1108,624296,1,1,,26748644,5281855,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1109,624296,1,1,,104171339,5281855,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1110,624297,1,1,,8139882,5281855,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1111,624297,1,1,,26748644,5281855,Inconclusive,7705682.0,51053.0,31.2384,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1112,624297,1,1,,104171339,5281855,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1113,624304,1,2,,8139882,5281855,Inactive,25148072.0,177343.0,,,uHTS identification of SKN-1 Inhibitors in a fluoresence assay,Screening,,
1114,624321,1,1,,8139882,5281855,Active,,,,,Early assessment of compound solubility in 1x PBS - Set 2,Other,,
1115,624323,1,1,,8139882,5281855,Active,,,,,Early assessment of compound solubility in aqueous buffer - Set 2,Other,,
1116,624330,1,2,,8139882,5281855,Inconclusive,21361397.0,29127.0,,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  Primary and Confirmatory Screens,Confirmatory,,
1117,624339,1,1,,8139882,5281855,Inactive,,,,,Parallel artificial membrane permeability assay at pH 7.4,Other,,
1118,624349,1,2,,92124524,5281855,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
1119,624352,1,1,,8139882,5281855,Inactive,40254439.0,2034.0,,,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Screening,,
1120,624354,1,1,,8139882,5281855,Inactive,224494019.0,8795.0,,,uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay,Screening,,
1121,624414,1,1,,8139882,5281855,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1122,624414,1,1,,124882878,5281855,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1123,624415,1,2,,8139882,5281855,Inactive,10092597.0,57192.0,,,qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1124,624417,1,1,,8139882,5281855,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
1125,624418,1,1,,8139882,5281855,Inactive,,,,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
1126,624452,1,1,,8139882,5281855,Unspecified,,,,,Human hepatic microsome stability-Set 2,Screening,,
1127,624463,1,1,,8139882,5281855,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
1128,624464,1,1,,8139882,5281855,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
1129,624465,1,1,,8139882,5281855,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
1130,624483,1,1,,8139882,5281855,Inactive,,,,,Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease,Screening,,
1131,639825,5,5,,103163815,5281855,Active,113596.0,231.0,0.2,IC50,Inhibition of human recombinant aldose reductase using D-glyceraldehyde as substrate preincubated for 10 mins before substrate addition measured for every 10 secs for 50 mins by spectrophotometry,Confirmatory,22261024.0,
1132,650674,5,5,,103163815,5281855,Active,60391226.0,207.0,3.34,IC50,Inhibition of human recombinant AKT1 expressed in Sf9 cells using GSK3(14-27) as substrate after 80 mins by scintillation counting,Confirmatory,22377675.0,
1133,650675,5,5,,103163815,5281855,Active,14424095.0,9891.0,0.51,IC50,Inhibition of human recombinant ARK5 expressed in Sf9 cells assessed as autophosphorylation after 80 mins by scintillation counting,Confirmatory,22377675.0,
1134,650676,5,5,,103163815,5281855,Active,27923855.0,6790.0,2.48,IC50,Inhibition of human recombinant aurora-A expressed in Sf9 cells using tetra(LRRWSLG) as substrate after 80 mins by scintillation counting,Confirmatory,22377675.0,
1135,650677,5,5,,103163815,5281855,Active,317373473.0,9212.0,2.5,IC50,Inhibition of human recombinant aurora-B expressed in Sf9 cells using tetra(LRRWSLG) as substrate after 80 mins by scintillation counting,Confirmatory,22377675.0,
1136,650678,5,5,,103163815,5281855,Active,50403720.0,673.0,1.76,IC50,Inhibition of human recombinant B-RAF expressed in Sf9 cells using MEK1 KM as substrate after 80 mins by scintillation counting,Confirmatory,22377675.0,
1137,650679,6,5,,103163815,5281855,Active,116051.0,1017.0,3.39,IC50,Inhibition of human recombinant CDK2/CyclinA expressed in Sf9 cells using histone H1 as substrate after 80 mins by scintillation counting,Confirmatory,22377675.0,
1138,650679,6,5,,103163815,5281855,Active,8134359.0,8900.0,3.39,IC50,Inhibition of human recombinant CDK2/CyclinA expressed in Sf9 cells using histone H1 as substrate after 80 mins by scintillation counting,Confirmatory,22377675.0,
1139,650679,6,5,,103163815,5281855,Active,311033358.0,890.0,3.39,IC50,Inhibition of human recombinant CDK2/CyclinA expressed in Sf9 cells using histone H1 as substrate after 80 mins by scintillation counting,Confirmatory,22377675.0,
1140,650680,6,5,,103163815,5281855,Active,116152.0,595.0,1.09,IC50,Inhibition of human recombinant CDK4/CyclinD1 expressed in Sf9 cells using RB-CTF as substrate after 80 mins by scintillation counting,Confirmatory,22377675.0,
1141,650680,6,5,,103163815,5281855,Active,1168867.0,1019.0,1.09,IC50,Inhibition of human recombinant CDK4/CyclinD1 expressed in Sf9 cells using RB-CTF as substrate after 80 mins by scintillation counting,Confirmatory,22377675.0,
1142,650681,5,5,,103163815,5281855,Active,2811086.0,1956.0,0.69,IC50,"Inhibition of human recombinant EGF-R expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting",Confirmatory,22377675.0,
1143,650682,5,5,,103163815,5281855,Active,19860819.0,2050.0,1.83,IC50,"Inhibition of human recombinant EPHB4 expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting",Confirmatory,22377675.0,
1144,650683,5,5,,103163815,5281855,Active,119533.0,2064.0,3.54,IC50,"Inhibition of human recombinant ERBB2 expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting",Confirmatory,22377675.0,
1145,650684,5,5,,103163815,5281855,Active,3183518.0,5747.0,3.11,IC50,"Inhibition of human recombinant FAK expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting",Confirmatory,22377675.0,
1146,650685,5,5,,103163815,5281855,Active,124240.0,3480.0,0.25,IC50,"Inhibition of human recombinant IGF1R expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting",Confirmatory,22377675.0,
1147,650686,5,5,,103163815,5281855,Active,125711.0,6714.0,0.8,IC50,"Inhibition of human recombinant SRC expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting",Confirmatory,22377675.0,
1148,650811,6,5,,103163815,5281855,Active,9087218.0,3791.0,0.79,IC50,"Inhibition of human recombinant VEGF-R2 expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting",Confirmatory,22377675.0,
1149,650812,5,5,,103163815,5281855,Active,357529070.0,2324.0,1.54,IC50,"Inhibition of human recombinant VEGF-R3 expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting",Confirmatory,22377675.0,
1150,650813,5,5,,103163815,5281855,Active,308153655.0,3643.0,0.34,IC50,"Inhibition of human recombinant INS-R expressed in Sf9 cells using poly(A,E,K,Y)6:2:5:1 as substrate after 80 mins by scintillation counting",Confirmatory,22377675.0,
1151,650814,5,5,,103163815,5281855,Active,251757497.0,4233.0,0.58,IC50,"Inhibition of human recombinant MET expressed in Sf9 cells using poly(A,E,K,Y)6:2:5:1 as substrate after 80 mins by scintillation counting",Confirmatory,22377675.0,
1152,650815,5,5,,103163815,5281855,Active,129890.0,5159.0,1.3,IC50,"Inhibition of human recombinant PDGFRbeta expressed in Sf9 cells using poly(A,E,K,Y)6:2:5:1 as substrate after 80 mins by scintillation counting",Confirmatory,22377675.0,
1153,650816,5,5,,103163815,5281855,Active,1709658.0,5347.0,3.34,IC50,Inhibition of human recombinant PLK1 expressed in Sf9 cells using casein as substrate after 80 mins by scintillation counting,Confirmatory,22377675.0,
1154,650817,5,5,,103163815,5281855,Active,160113150.0,10733.0,2.97,IC50,Inhibition of human recombinant SAK expressed in Sf9 cells using p38alpha-KRKR as substrate after 80 mins by scintillation counting,Confirmatory,22377675.0,
1155,650818,5,5,,103163815,5281855,Active,218511853.0,7010.0,0.26,IC50,"Inhibition of human recombinant TIE2 expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting",Confirmatory,22377675.0,
1156,650819,5,5,,103163815,5281855,Active,50403742.0,1326.0,2.37,IC50,Inhibition of human recombinant COT expressed in Sf9 cells assessed as autophosphorylation after 80 mins by scintillation counting,Confirmatory,22377675.0,
1157,651550,1,1,,8139882,5281855,Inactive,60391226.0,207.0,,,HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen,Screening,,
1158,651560,1,1,,8139882,5281855,Active,1709543.0,52.0,,,"uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay",Screening,,
1159,651582,1,1,,8139882,5281855,Inactive,,,,,uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay,Screening,,
1160,651631,4,1,,144204356,5281855,Inconclusive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
1161,651632,4,1,,144204356,5281855,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
1162,651633,4,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
1163,651634,4,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
1164,651635,1,3,,8139882,5281855,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1165,651636,1,1,,8139882,5281855,Inactive,4826706.0,1880.0,,,uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay,Screening,,
1166,651644,1,1,,8139882,5281855,Inactive,28872817.0,155807.0,,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
1167,651647,1,1,,8139882,5281855,Inactive,4826834.0,4323.0,,,uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay,Screening,,
1168,651654,1,1,,8139882,5281855,Inactive,,,,,HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1169,651687,1,1,,8139882,5281855,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1170,651699,1,1,,8139882,5281855,Inactive,4502169.0,8883.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
1171,651699,1,1,,8139882,5281855,Inactive,4507791.0,9040.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
1172,651702,1,2,,8139882,5281855,Inactive,,,,,Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library,Screening,,
1173,651723,1,1,,8139882,5281855,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity,Screening,,
1174,651724,1,1,,8139882,5281855,Inactive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
1175,651725,1,1,,8139882,5281855,Active,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
1176,651819,1,1,,8139882,5281855,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
1177,651820,1,1,,8139882,5281855,Inactive,,,,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
1178,651965,1,1,,8139882,5281855,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
1179,651965,1,1,,124882878,5281855,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
1180,651999,1,1,,8139882,5281855,Inactive,38027923.0,10987.0,,,"uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay",Screening,,
1181,652025,1,1,,8139882,5281855,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
1182,652048,1,2,,8139882,5281855,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
1183,652048,1,2,,144204356,5281855,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
1184,652051,1,1,,8139882,5281855,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
1185,652051,1,1,,144204356,5281855,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
1186,652054,1,1,,8139882,5281855,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
1187,652104,1,1,,8139882,5281855,Inactive,20140568.0,23435.0,,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
1188,652105,1,1,,8139882,5281855,Active,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
1189,652106,1,1,,8139882,5281855,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
1190,652106,1,1,,124882878,5281855,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
1191,663955,3,6,,103163815,5281855,Active,68068087.0,2859.0,0.11,EC50,Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay,Confirmatory,24900447.0,
1192,663956,3,6,,103163815,5281855,Active,68068087.0,2859.0,2.96,EC50,Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay,Confirmatory,24900447.0,
1193,663960,5,5,,103163815,5281855,Active,68068087.0,2859.0,0.1,IC50,Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins,Confirmatory,24900447.0,
1194,663961,1,8,,103163815,5281855,Unspecified,68068087.0,2859.0,,,Agonist activity at GPR35 receptor in human HT-29 cells assessed as shift in resonant wavelength of biosensor stimulation after 10 mins by dynamic mass redistribution assay relative to control,Other,24900447.0,
1195,663962,1,8,,103163815,5281855,Unspecified,68068087.0,2859.0,,,Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay relative to control,Other,24900447.0,
1196,663966,1,8,,103163815,5281855,Inactive,68068087.0,2859.0,,,Agonist activity at GPR35 receptor in human HT-29 cells at 2 uM after 10 mins by dynamic mass redistribution assay in the presence of SPB05142,Other,24900447.0,
1197,671063,1,2,,103163815,5281855,Unspecified,,,,,Inhibition of CPE-induced MMP1 mRNA expression in human SAE cells after 24 hrs by quantitative RT-PCR analysis,Other,22739086.0,
1198,671064,1,2,,103163815,5281855,Active,,,,,Inhibition of MMP1 mRNA expression in human SAE cells at 1 to 10 ug/ml after 24 hrs by quantitative RT-PCR analysis,Other,22739086.0,
1199,671065,1,2,,103163815,5281855,Unspecified,,,,,Inhibition of CPE-induced MMP1 mRNA expression in human SAE cells after 24 hrs by quantitative RT-PCR analysis relative to control,Other,22739086.0,
1200,671066,1,3,,103163815,5281855,Unspecified,,,,,Cytotoxicity against human SAE cells at 1 to 10 ug/ml,Other,22739086.0,
1201,679371,1,8,,103163815,5281855,Unspecified,74762955.0,9356.0,,,TP_TRANSPORTER: uptake in Xenopus laevis oocytes,Other,15870380.0,
1202,679387,2,6,,103163815,5281855,Unspecified,74762955.0,9356.0,0.27,IC50,TP_TRANSPORTER: inhibition of ochratoxin A uptake (ochratoxin A / 1uM) in Xenopus laevis oocytes,Confirmatory,15870380.0,
1203,680166,1,7,,103163815,5281855,Unspecified,74734337.0,55867.0,,,TP_TRANSPORTER: inhibition of p-aminohippurate uptake (p-aminohippurate / 10uM) by ellagic acid at a concentration of 35uM in Xenopus laevis oocytes,Other,15870380.0,
1204,681675,1,7,,103163815,5281855,Unspecified,74734337.0,55867.0,,,TP_TRANSPORTER: uptake in Xenopus laevis oocytes,Other,15870380.0,
1205,686970,1,2,,8139882,5281855,Inconclusive,49168486.0,3417.0,0.13,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
1206,686971,1,2,,8139882,5281855,Inconclusive,,,0.7308,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
1207,686978,1,1,,8139882,5281855,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1208,686978,1,1,,124882875,5281855,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1209,686978,1,1,,124882878,5281855,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1210,686978,1,1,,144204356,5281855,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1211,686979,1,1,,8139882,5281855,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1212,686979,1,1,,124882875,5281855,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1213,686979,1,1,,124882878,5281855,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1214,686979,1,1,,144204356,5281855,Inconclusive,79154014.0,55775.0,29.0929,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1215,689521,1,2,,103163815,5281855,Inactive,,,,,"Antitumor activity against mouse B16 cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 0.5 mg/kg, po administered for 1 week prior to tumor injection followed by treatment for additional 2 weeks relative to vehicle-treated control",Other,23185648.0,
1216,689522,1,2,,103163815,5281855,Unspecified,,,,,"Toxicity in C57BL/6 mouse xenografted with B16 cells assessed as adverse effects at 0.5 mg/kg, po administered for 1 week prior to tumor injection followed by treatment for additional 2 weeks relative to vehicle-treated control",Other,23185648.0,
1217,689524,1,3,,103163815,5281855,Inactive,,,,,"Immunoenhancing activity in C57BL/6 mouse assessed as increase in total immune cells in bone marrow at 0.5 mg/kg, po administered for 1 week by trypan blue exclusion method relative to vehicle-treated control",Other,23185648.0,
1218,689525,1,3,,103163815,5281855,Inactive,,,,,"Immunoenhancing activity in C57BL/6 mouse assessed as increase in total immune cells in liver at 0.5 mg/kg, po administered for 1 week by trypan blue exclusion method relative to vehicle-treated control",Other,23185648.0,
1219,689526,1,3,,103163815,5281855,Inactive,,,,,"Immunoenhancing activity in C57BL/6 mouse assessed as increase in immune subset cells in bone marrow at 0.5 mg/kg, po administered for 1 week by flow cytometric analysis relative to vehicle-treated control",Other,23185648.0,
1220,689527,1,3,,103163815,5281855,Inactive,,,,,"Immunoenhancing activity in C57BL/6 mouse assessed as increase in immune subset cells in liver at 0.5 mg/kg, po administered for 1 week by flow cytometric analysis relative to vehicle-treated control",Other,23185648.0,
1221,689528,1,2,,103163815,5281855,Unspecified,,,,,"Immunomodulatory activity in C57BL/6 mouse NK cells expressing NK1.1 and CD3 assessed as cell surface CD107a expression level at 0.5 mg/kg, po administered for 1 week by YAC1 co culture-based immunostaining analysis (Rvb = 41.5%)",Other,23185648.0,
1222,689529,1,2,,103163815,5281855,Unspecified,,,,,"Immunomodulatory activity in C57BL/6 mouse CD3-deficient NK cells expressing NK1.1 assessed as IL8- and IL-18 induced IFNgamma level at 0.5 mg/kg, po administered for 1 week by flow cytometric analysis (Rvb = 76.7%)",Other,23185648.0,
1223,689530,1,2,,103163815,5281855,Unspecified,,,,,"Toxicity in C57BL/6 mouse assessed as change in body weight at 0.5 mg/kg, po administered for 3 weeks relative to vehicle-treated control",Other,23185648.0,
1224,689531,1,3,,103163815,5281855,Unspecified,,,,,"Toxicity in C57BL/6 mouse assessed as change in liver weight at 0.5 mg/kg, po administered for 3 weeks relative to vehicle-treated control",Other,23185648.0,
1225,689532,1,3,,103163815,5281855,Unspecified,,,,,"Toxicity in C57BL/6 mouse assessed as change in spleen weight at 0.5 mg/kg, po administered for 3 weeks relative to vehicle-treated control",Other,23185648.0,
1226,689533,1,2,,103163815,5281855,Active,,,,,Growth inhibition of mouse B16 cells at 10 uM after 24 to 96 hrs by trypan blue exclusion assay,Other,23185648.0,
1227,689534,1,2,,103163815,5281855,Unspecified,,,,,Induction of apoptosis in mouse B16 cells assessed as early apoptotic cells at 10 uM after 72 hrs by AnnexinV/PI staining-based flow cytometric analysis (Rvb = 2.28%),Other,23185648.0,
1228,689535,1,2,,103163815,5281855,Unspecified,,,,,Induction of apoptosis in mouse B16 cells assessed as late apoptotic cells at 10 uM after 72 hrs by AnnexinV/PI staining-based flow cytometric analysis (Rvb = 2.48%),Other,23185648.0,
1229,689536,1,2,,103163815,5281855,Unspecified,,,,,Induction of apoptosis in mouse B16 cells assessed as necrotic cells at 10 uM after 72 hrs by AnnexinV/PI staining-based flow cytometric analysis (Rvb = 5.26%),Other,23185648.0,
1230,689537,1,2,,103163815,5281855,Unspecified,,,,,Induction of apoptosis in mouse B16 cells assessed as viable cells at 10 uM after 72 hrs by AnnexinV/PI staining-based flow cytometric analysis (Rvb = 90%),Other,23185648.0,
1231,689538,1,2,,103163815,5281855,Active,,,,,Induction of apoptosis in mouse B16 cells assessed as decrease in Bcl2 expression at 10 uM after 72 hrs by Western blot analysis,Other,23185648.0,
1232,697852,1,7,,103163815,5281855,Unspecified,14916521.0,,,,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,Other,23062825.0,
1233,697853,1,7,,103163815,5281855,Unspecified,21362409.0,100033901.0,,,Inhibition of horse BChE at 2 mg/ml by Ellman's method,Other,23062825.0,
1234,711597,1,2,,103163815,5281855,Active,,,,,Increase of lifespan of Caenorhabditis elegans assessed as ascorbic acid equivalent of water soluble antioxidant metabolites at 50 uM by photochemiluminescence assay,Other,21805983.0,
1235,711608,1,2,,103163815,5281855,Inactive,,,,,Reduction of frequency of pharyngeal pumping in Caenorhabditis elegans at 50 uM on 3rd to 9th day of adulthood,Other,21805983.0,
1236,711611,1,2,,103163815,5281855,Active,,,,,Reduction of initial reproduction rate in Caenorhabditis elegans assessed as first egg deposition at 50 uM after 85 hrs,Other,21805983.0,
1237,711614,1,2,,103163815,5281855,Active,,,,,Reduction of body length of L4 larvae of Caenorhabditis elegans at 50 uM by microscopic analysis,Other,21805983.0,
1238,711618,1,2,,103163815,5281855,Active,,,,,Increase of lifespan of L4 larvae of Caenorhabditis elegans at 50 uM in presence of heat killed bacteria,Other,21805983.0,
1239,711619,1,2,,103163815,5281855,Unspecified,,,,,Increase of lifespan of L4 larvae of Caenorhabditis elegans assessed as lifespan increasing concentration after 8 hrs,Other,21805983.0,
1240,711622,1,2,,103163815,5281855,Inactive,,,,,Increase of lifespan of L4 larvae of Caenorhabditis elegans after 8 hrs in presence of H2O2,Other,21805983.0,
1241,711623,1,2,,103163815,5281855,Unspecified,,,,,Toxicity in L4 larvae of Caenorhabditis elegans at 800 uM after 8 hrs,Other,21805983.0,
1242,720504,1,1,,8139882,5281855,Active,21359873.0,5347.0,8.4368,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
1243,720516,2,1,,144204356,5281855,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1244,720532,1,1,,124882875,5281855,Active,420597.0,,3.5481,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1245,720532,1,1,,144204356,5281855,Active,420597.0,,0.996,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1246,720533,1,1,,124882875,5281855,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1247,720533,1,1,,144204356,5281855,Inactive,,,1.1175,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1248,720542,1,2,,8139882,5281855,Active,23496270.0,810891.0,0.7943,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
1249,720551,1,2,,8139882,5281855,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
1250,720552,2,1,,144204356,5281855,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1251,720553,1,2,,8139882,5281855,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
1252,720579,2,1,,8139882,5281855,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1253,720579,2,1,,124882878,5281855,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1254,720579,2,1,,144204356,5281855,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1255,720580,1,1,,8139882,5281855,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1256,720580,1,1,,124882878,5281855,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1257,720580,1,1,,144204356,5281855,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1258,720634,2,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1259,720635,2,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1260,720637,2,1,,144204356,5281855,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1261,720674,2,2,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1262,720675,2,2,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1263,720678,2,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1264,720679,2,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1265,720680,2,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1266,720681,2,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1267,720682,2,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1268,720683,2,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1269,720684,2,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1270,720685,2,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1271,720686,2,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1272,720687,2,2,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1273,720691,4,1,,144204356,5281855,Inactive,311348376.0,2908.0,2.6832,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1274,720692,3,1,,144204356,5281855,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1275,720693,3,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1276,720707,1,2,,8139882,5281855,Inactive,317373593.0,10411.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
1277,720708,1,2,,8139882,5281855,Inactive,32171491.0,11069.0,19.9526,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
1278,720709,1,2,,8139882,5281855,Inconclusive,317373593.0,10411.0,10.0,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
1279,720711,1,2,,8139882,5281855,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
1280,720717,1,3,,92124524,5281855,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
1281,720719,2,1,,144204356,5281855,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1282,720725,2,1,,144204356,5281855,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1283,729558,2,5,,103163815,5281855,Active,30580350.0,377677.0,4.24,Ki,Inhibition of human carbonic anhydrase 13 preincubated for 6 hrs by CO2 hydration stopped-flow assay,Confirmatory,22892213.0,
1284,729559,2,5,,103163815,5281855,Active,5915866.0,771.0,8.15,Ki,Inhibition of human carbonic anhydrase 12 preincubated for 6 hrs by CO2 hydration stopped-flow assay,Confirmatory,22892213.0,
1285,729560,2,5,,103163815,5281855,Unspecified,83300925.0,768.0,79.8,Ki,Inhibition of human carbonic anhydrase 9 preincubated for 6 hrs by CO2 hydration stopped-flow assay,Confirmatory,22892213.0,
1286,729561,2,5,,103163815,5281855,Active,1168744.0,766.0,8.79,Ki,Inhibition of human carbonic anhydrase 7 preincubated for 6 hrs by CO2 hydration stopped-flow assay,Confirmatory,22892213.0,
1287,729562,2,5,,103163815,5281855,Unspecified,115456.0,760.0,100.0,Ki,Inhibition of human carbonic anhydrase 2 preincubated for 6 hrs by CO2 hydration stopped-flow assay,Confirmatory,22892213.0,
1288,729563,2,5,,103163815,5281855,Unspecified,115449.0,759.0,68.2,Ki,Inhibition of human carbonic anhydrase 1 preincubated for 6 hrs by CO2 hydration stopped-flow assay,Confirmatory,22892213.0,
1289,743012,3,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1290,743014,3,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1291,743015,3,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1292,743033,3,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1293,743035,2,1,,144204356,5281855,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1294,743036,2,1,,144204356,5281855,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1295,743040,3,1,,144204356,5281855,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1296,743041,3,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1297,743042,3,1,,144204356,5281855,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1298,743053,2,1,,144204356,5281855,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1299,743054,2,1,,144204356,5281855,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1300,743063,2,1,,144204356,5281855,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1301,743064,3,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1302,743065,3,1,,144204356,5281855,Inconclusive,399498506.0,24831.0,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1303,743066,3,1,,144204356,5281855,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1304,743067,2,1,,144204356,5281855,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1305,743069,2,1,,144204356,5281855,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1306,743074,2,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1307,743075,2,1,,144204356,5281855,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1308,743077,2,1,,144204356,5281855,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1309,743078,2,1,,144204356,5281855,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1310,743079,3,1,,144204356,5281855,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1311,743080,3,1,,144204356,5281855,Inactive,348019627.0,2099.0,23.7101,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1312,743081,3,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1313,743083,3,1,,144204356,5281855,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1314,743084,3,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1315,743085,3,1,,144204356,5281855,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1316,743086,3,1,,144204356,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1317,743091,2,1,,144204356,5281855,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1318,743094,3,1,,144204356,5281855,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1319,743122,2,1,,144204356,5281855,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1320,743139,2,1,,144204356,5281855,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1321,743140,2,1,,144204356,5281855,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1322,743191,3,1,,170466649,5281855,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1323,743194,3,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1324,743199,2,1,,170466649,5281855,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1325,743202,4,1,,170466649,5281855,Inconclusive,20149576.0,4780.0,0.5172,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1326,743203,3,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1327,743209,3,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1328,743210,4,1,,170466649,5281855,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1329,743211,3,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1330,743212,3,1,,170466649,5281855,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1331,743213,3,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1332,743215,3,1,,170466649,5281855,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1333,743217,3,1,,170466649,5281855,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1334,743218,3,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1335,743219,3,1,,170466649,5281855,Inconclusive,20149576.0,4780.0,0.651125,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1336,743220,3,1,,170466649,5281855,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1337,743221,3,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1338,743222,3,1,,170466649,5281855,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1339,743223,3,1,,170466649,5281855,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1340,743224,3,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1341,743225,3,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1342,743226,2,1,,170466649,5281855,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1343,743227,2,1,,170466649,5281855,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1344,743228,3,1,,170466649,5281855,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1345,743239,2,1,,170466649,5281855,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1346,743240,2,1,,170466649,5281855,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1347,743241,2,1,,170466649,5281855,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1348,743242,2,1,,170466649,5281855,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1349,743244,1,1,,144204356,5281855,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1350,743255,1,1,,8139882,5281855,Inconclusive,118600387.0,7398.0,44.6684,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
1351,743266,1,2,,8139882,5281855,Inactive,296080761.0,5745.0,,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
1352,743279,1,2,,8139882,5281855,Active,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
1353,743344,1,1,,174007273,5281855,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
1354,743345,1,1,,174007273,5281855,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
1355,743346,1,1,,174007273,5281855,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation (Rep 2),Confirmatory,,
1356,743347,1,1,,174007273,5281855,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
1357,757709,1,1,,103163815,5281855,Active,,,0.04,IC50,Inhibition of human recombinant CK2 expressed in Escherichia coli BL21(DE3) using RRRDDDSDDD as substrate after 15 mins by capillary electrophoretic analysis,Confirmatory,23711832.0,
1358,757712,1,1,,103163815,5281855,Unspecified,,,,,Inhibition of human recombinant CK2 expressed in Escherichia coli BL21(DE3) using RRRDDDSDDD as substrate at 10 uM after 15 mins by capillary electrophoretic analysis relative to control,Other,23711832.0,
1359,768965,1,3,,103163815,5281855,Unspecified,,,,,Antioxidant activity assessed as effective concentration for potassium ferric cyanide ion reducing power equivalent of 0.5 absorbance ellagic acid at 100 to 1000 ug/ml after 20 mins by FRAP assay,Other,,
1360,977599,1,1,,103163815,5281855,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
1361,977602,1,2,,103163815,5281855,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
1362,977610,3,1,,170481926,5281855,Active,225697983.0,,0.02,Ki,Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB,Other,19414254.0,
1363,1096882,2,3,,103163815,5281855,Active,1168407.0,24192.0,0.19952999999999999,IC50,Inhibition of Rattus norvegicus (rat) lens aldose reductase,Confirmatory,,
1364,1100608,1,1,,103163815,5281855,Inactive,,,,,Antibacterial activity against Ralstonia solanacearum grown on potato semi-synthetic agar medium at 5 umol/disk by paper disk method,Other,84.0,
1365,1100609,1,1,,103163815,5281855,Inactive,,,,,Antibacterial activity against Ralstonia solanacearum grown on potato semi-synthetic agar medium at 0.5 umol/disk by paper disk method,Other,84.0,
1366,1110806,1,1,,103163815,5281855,Active,,,9.3,IC50,Inhibition of xanthine oxidase assessed as conversion of xanthine to uric acid incubated for 3 min,Confirmatory,15652581.0,
1367,1110807,1,1,,103163815,5281855,Unspecified,,,,,Antimicrobial activity against Candida albicans at 100 ug after 24 hr by disk diffusion method,Other,15652581.0,
1368,1110808,1,2,,103163815,5281855,Unspecified,,,,,Antimicrobial activity against Corynebacterium accolens at 100 ug after 24 hr by disk diffusion method,Other,15652581.0,
1369,1110809,1,1,,103163815,5281855,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus at 100 ug after 24 hr by disk diffusion method,Other,15652581.0,
1370,1110810,1,1,,103163815,5281855,Unspecified,,,,,Antimicrobial activity against Pectobacterium carotovorum at 100 ug after 24 hr by disk diffusion method,Other,15652581.0,
1371,1117298,1,2,,170466649,5281855,Inactive,,,6.3096,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel",Confirmatory,,
1372,1117304,1,2,,170466649,5281855,Active,,,11.2202,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel",Confirmatory,,
1373,1117305,1,2,,170466649,5281855,Active,,,11.2202,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel",Confirmatory,,
1374,1117310,1,1,,170466649,5281855,Inactive,,,6.30957,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel",Confirmatory,,
1375,1117312,1,1,,170466649,5281855,Active,,,11.2202,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel",Confirmatory,,
1376,1117314,1,1,,170466649,5281855,Inactive,,,11.2202,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel",Confirmatory,,
1377,1117319,1,2,,8139882,5281855,Active,9629361.0,155459.0,0.45,Average IC50,High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction,Confirmatory,,
1378,1117319,1,2,,8139882,5281855,Active,13399304.0,60489.0,0.45,Average IC50,High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction,Confirmatory,,
1379,1117324,1,1,,170466649,5281855,Inactive,,,10.0,IC50,VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50,Confirmatory,,
1380,1117326,1,1,,170466649,5281855,Inactive,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
1381,1117329,1,1,,170466649,5281855,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
1382,1117336,1,1,,170466649,5281855,Inactive,,,,,GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen,Screening,,
1383,1117337,1,1,,170466649,5281855,Inactive,,,10.0,IC50,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50,Confirmatory,,
1384,1117340,1,1,,170466649,5281855,Active,,,,,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-screen,Screening,,
1385,1117341,1,1,,170466649,5281855,Inactive,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
1386,1117342,1,1,,170466649,5281855,Inactive,,,,,HCT116 viability from Cell TiterGlo-screen,Screening,,
1387,1117343,1,1,,170466649,5281855,Active,,,,,SW480 viability from Cell TiterGlo-screen,Screening,,
1388,1117346,1,1,,170466649,5281855,Inactive,,,,,DLD-1 viability from Cell TiterGlo-screen,Screening,,
1389,1117359,1,1,,8139882,5281855,Inactive,,,,CC50,A cell based assay for assessing THP-1 cell cytotoxicity of Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G,Confirmatory,,
1390,1117361,1,1,,8139882,5281855,Active,9629358.0,155871.0,1.669,Average IC50,An HIV-1 Tat-TAR Fluorescence Polarization (FP) Counter Screen to evaluate Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G,Confirmatory,,
1391,1117362,1,2,,8139882,5281855,Inactive,1389744.0,,,Average IC50,A TR-FRET Counter Screen assay to evaluate Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G,Confirmatory,,
1392,1126471,1,3,,103163815,5281855,Unspecified,67476665.0,2053.0,,,Inhibition of sEH (unknown origin) assessed as substrate PHOME hydrolysis at 25 uM after 1 hr by fluorescence method,Other,24679441.0,
1393,1126472,3,2,,103163815,5281855,Active,67476665.0,2053.0,20.7,IC50,Inhibition of sEH (unknown origin) assessed as substrate PHOME hydrolysis after 1 hr by fluorescence method,Confirmatory,24679441.0,
1394,1126473,1,1,,103163815,5281855,Unspecified,,,,,Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 50 uM after 18 hrs by MTT assay in presence of LPS,Other,24679441.0,
1395,1126474,1,1,,103163815,5281855,Inactive,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 10 uM after 18 hrs by griess reaction analysis,Other,24679441.0,
1396,1126475,1,1,,103163815,5281855,Inactive,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 0.4 uM after 18 hrs by griess reaction analysis,Other,24679441.0,
1397,1126476,1,1,,103163815,5281855,Active,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion at 10 uM after 18 hrs by sandwich ELISA,Other,24679441.0,
1398,1126477,1,1,,103163815,5281855,Inactive,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion at 0.4 uM after 18 hrs by sandwich ELISA,Other,24679441.0,
1399,1126478,1,1,,103163815,5281855,Active,,,35.7,IC50,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 18 hrs by griess reaction analysis,Confirmatory,24679441.0,
1400,1126479,1,1,,103163815,5281855,Unspecified,,,50.0,IC50,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion after 18 hrs by sandwich ELISA,Confirmatory,24679441.0,
1401,1153318,3,2,,103163815,5281855,Active,296434407.0,23621.0,3.9,IC50,Inhibition of BACE1 (unknown origin),Confirmatory,24835197.0,
1402,1159509,1,1,,170466649,5281855,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1403,1159515,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1404,1159516,1,1,,170466649,5281855,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1405,1159517,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1406,1159518,1,1,,170466649,5281855,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1407,1159519,1,1,,170466649,5281855,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1408,1159520,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1409,1159521,1,1,,170466649,5281855,Inconclusive,15928672.0,19885.0,12.99,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1410,1159523,1,1,,170466649,5281855,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1411,1159524,1,1,,8139882,5281855,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1412,1159524,1,1,,144204356,5281855,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1413,1159525,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1414,1159526,1,1,,170466649,5281855,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1415,1159527,1,1,,170466649,5281855,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1416,1159528,1,1,,170466649,5281855,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1417,1159529,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1418,1159531,1,1,,170466649,5281855,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1419,1159550,3,1,,252403040,5281855,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
1420,1159551,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1421,1159552,1,1,,170466649,5281855,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1422,1159553,2,1,,170466649,5281855,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1423,1159555,1,1,,170466649,5281855,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1424,1159580,2,1,,268736065,5281855,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
1425,1159606,1,1,,8139882,5281855,Active,,,,,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Other,,
1426,1159607,2,1,,312995600,5281855,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
1427,1159614,1,2,,170466649,5281855,Inactive,22328079.0,2581.0,,Potency,A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase,Confirmatory,,
1428,1160653,1,2,,103163815,5281855,Active,308153622.0,10498.0,25.0,IC50,Inhibition of CARM-1 (unknown origin) using Histone H3 Arg-17 as substrate,Confirmatory,,
1429,1167184,1,1,,103163815,5281855,Unspecified,,,,,Inhibition of human recombinant CK2a1/CK2b holoenzyme expressed in Escherichia coli BL21(DE3) at 10 uM pre-incubated for 10 mins before substrate addition by capillary electrophoresis based assay,Other,25272055.0,
1430,1167185,1,1,,103163815,5281855,Active,,,0.04,IC50,Inhibition of human recombinant CK2a1/CK2b holoenzyme expressed in Escherichia coli BL21(DE3) pre-incubated for 10 mins before substrate addition by capillary electrophoresis based assay,Confirmatory,25272055.0,
1431,1199266,1,2,,103163815,5281855,Unspecified,308153622.0,10498.0,,,Inhibition of CARM1 in human HeLa cells assessed as reduction of H3R17 methylation at 5 uM after 24 hrs by Western blot analysis relative to control,Other,25406853.0,
1432,1224817,1,1,,477072,5281855,Inactive,,,,,Assays to identify small molecules inhibitory for eIF4E expression,Other,26144883.0,
1433,1224824,1,1,,174007273,5281855,Inactive,,,20.930999999999997,Potency,High-throughput drug toxicity screening in the BPDCN cell line Gen2.2,Confirmatory,,
1434,1224825,1,1,,174007273,5281855,Inactive,,,,Potency,High-throughput drug toxicity screening in the BPDCN cell line Cal-1,Confirmatory,,
1435,1224834,3,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1436,1224835,1,1,,170466649,5281855,Active,160794.0,,11.9877,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1437,1224836,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1438,1224837,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1439,1224838,1,1,,170466649,5281855,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1440,1224839,1,1,,170466649,5281855,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1441,1224840,3,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1442,1224841,3,1,,170466649,5281855,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1443,1224842,3,1,,170466649,5281855,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1444,1224843,1,1,,170466649,5281855,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1445,1224844,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1446,1224845,1,1,,170466649,5281855,Inconclusive,344243002.0,100757539.0,19.0843,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1447,1224846,1,1,,170466649,5281855,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1448,1224847,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1449,1224848,3,1,,170466649,5281855,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1450,1224849,3,1,,170466649,5281855,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1451,1224857,2,1,,170466649,5281855,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1452,1224857,2,1,,174007273,5281855,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1453,1224859,2,1,,170466649,5281855,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1454,1224859,2,1,,174007273,5281855,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1455,1224863,1,1,,316919752,5281855,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
1456,1224865,1,2,,8139882,5281855,Inactive,578162.0,,,,Identify inhibitors of HNF4 alpha protein binding to DNA,Screening,,
1457,1224867,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1458,1224868,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1459,1224869,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1460,1224870,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1461,1224871,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1462,1224872,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1463,1224873,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1464,1224874,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1465,1224875,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1466,1224876,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1467,1224877,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1468,1224878,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1469,1224879,1,1,,170466649,5281855,Inconclusive,,,11.6795,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1470,1224880,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1471,1224881,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1472,1224882,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1473,1224883,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1474,1224884,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1475,1224885,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1476,1224886,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1477,1224887,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1478,1224888,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1479,1224889,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1480,1224890,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1481,1224892,1,1,,170466649,5281855,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1482,1224893,1,1,,170466649,5281855,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1483,1224894,1,1,,170466649,5281855,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1484,1224895,1,1,,170466649,5281855,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1485,1224896,1,1,,170466649,5281855,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1486,1259241,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1487,1259242,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1488,1259243,1,1,,170466649,5281855,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1489,1259244,1,1,,170466649,5281855,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1490,1259247,1,1,,170466649,5281855,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1491,1259248,1,1,,170466649,5281855,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1492,1259252,1,1,,174007273,5281855,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (RDES),Confirmatory,,
1493,1259253,1,1,,174007273,5281855,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC71),Confirmatory,,
1494,1259255,1,1,,174007273,5281855,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (EW8),Confirmatory,,
1495,1259256,1,1,,174007273,5281855,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC32),Confirmatory,,
1496,1259310,1,1,,321946355,5281855,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1497,1259310,1,1,,333473298,5281855,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1498,1259310,1,1,,333473458,5281855,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1499,1259313,1,1,,8139882,5281855,Inactive,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
1500,1259344,1,1,,144204356,5281855,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
1501,1259355,1,1,,26748644,5281855,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
1502,1259356,1,1,,144204356,5281855,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
1503,1259364,1,1,,170466649,5281855,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1504,1259365,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1505,1259366,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1506,1259367,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1507,1259368,1,1,,170466649,5281855,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1508,1259369,1,1,,170466649,5281855,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1509,1259377,1,1,,170466649,5281855,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1510,1259378,1,1,,170466649,5281855,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1511,1259379,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1512,1259380,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1513,1259381,1,1,,170466649,5281855,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1514,1259382,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1515,1259383,1,1,,170466649,5281855,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1516,1259384,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1517,1259385,1,1,,170466649,5281855,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1518,1259386,1,1,,170466649,5281855,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1519,1259387,1,1,,170466649,5281855,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1520,1259388,1,1,,170466649,5281855,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1521,1259389,1,1,,124634213,5281855,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
1522,1259390,1,1,,170466649,5281855,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1523,1259391,1,1,,170466649,5281855,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1524,1259392,1,1,,170466649,5281855,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1525,1259393,1,1,,170466649,5281855,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1526,1259394,1,1,,170466649,5281855,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1527,1259395,1,1,,170466649,5281855,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1528,1259396,1,1,,170466649,5281855,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1529,1259400,1,1,,170466649,5281855,Inactive,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
1530,1259401,1,1,,170466649,5281855,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1531,1259402,1,1,,170466649,5281855,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1532,1259403,1,1,,170466649,5281855,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1533,1259404,1,1,,170466649,5281855,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1534,1259407,1,1,,363898724,5281855,Inactive,,,,,CCRIS mutagenicity studies,Other,,
1535,1259409,1,1,,363898724,5281855,Unspecified,,,,,CCRIS tumor inhibitor studies,Other,,
1536,1259416,1,2,,340084667,5281855,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1537,1259416,1,2,,375178141,5281855,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1538,1259421,1,1,,340084667,5281855,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
1539,1259421,1,1,,375178141,5281855,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
1540,1259423,1,2,,354909941,5281855,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
